[{"path":"/LICENSE.html","id":null,"dir":"","previous_headings":"","what":"GNU General Public License","title":"GNU General Public License","text":"Version 3, 29 June 2007Copyright © 2007 Free Software Foundation, Inc. <http://fsf.org/> Everyone permitted copy distribute verbatim copies license document, changing allowed.","code":""},{"path":"/LICENSE.html","id":"preamble","dir":"","previous_headings":"","what":"Preamble","title":"GNU General Public License","text":"GNU General Public License free, copyleft license software kinds works. licenses software practical works designed take away freedom share change works. contrast, GNU General Public License intended guarantee freedom share change versions program–make sure remains free software users. , Free Software Foundation, use GNU General Public License software; applies also work released way authors. can apply programs, . speak free software, referring freedom, price. General Public Licenses designed make sure freedom distribute copies free software (charge wish), receive source code can get want , can change software use pieces new free programs, know can things. protect rights, need prevent others denying rights asking surrender rights. Therefore, certain responsibilities distribute copies software, modify : responsibilities respect freedom others. example, distribute copies program, whether gratis fee, must pass recipients freedoms received. must make sure , , receive can get source code. must show terms know rights. Developers use GNU GPL protect rights two steps: (1) assert copyright software, (2) offer License giving legal permission copy, distribute /modify . developers’ authors’ protection, GPL clearly explains warranty free software. users’ authors’ sake, GPL requires modified versions marked changed, problems attributed erroneously authors previous versions. devices designed deny users access install run modified versions software inside , although manufacturer can . fundamentally incompatible aim protecting users’ freedom change software. systematic pattern abuse occurs area products individuals use, precisely unacceptable. Therefore, designed version GPL prohibit practice products. problems arise substantially domains, stand ready extend provision domains future versions GPL, needed protect freedom users. Finally, every program threatened constantly software patents. States allow patents restrict development use software general-purpose computers, , wish avoid special danger patents applied free program make effectively proprietary. prevent , GPL assures patents used render program non-free. precise terms conditions copying, distribution modification follow.","code":""},{"path":[]},{"path":"/LICENSE.html","id":"id_0-definitions","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"0. Definitions","title":"GNU General Public License","text":"“License” refers version 3 GNU General Public License. “Copyright” also means copyright-like laws apply kinds works, semiconductor masks. “Program” refers copyrightable work licensed License. licensee addressed “”. “Licensees” “recipients” may individuals organizations. “modify” work means copy adapt part work fashion requiring copyright permission, making exact copy. resulting work called “modified version” earlier work work “based ” earlier work. “covered work” means either unmodified Program work based Program. “propagate” work means anything , without permission, make directly secondarily liable infringement applicable copyright law, except executing computer modifying private copy. Propagation includes copying, distribution (without modification), making available public, countries activities well. “convey” work means kind propagation enables parties make receive copies. Mere interaction user computer network, transfer copy, conveying. interactive user interface displays “Appropriate Legal Notices” extent includes convenient prominently visible feature (1) displays appropriate copyright notice, (2) tells user warranty work (except extent warranties provided), licensees may convey work License, view copy License. interface presents list user commands options, menu, prominent item list meets criterion.","code":""},{"path":"/LICENSE.html","id":"id_1-source-code","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"1. Source Code","title":"GNU General Public License","text":"“source code” work means preferred form work making modifications . “Object code” means non-source form work. “Standard Interface” means interface either official standard defined recognized standards body, , case interfaces specified particular programming language, one widely used among developers working language. “System Libraries” executable work include anything, work whole, () included normal form packaging Major Component, part Major Component, (b) serves enable use work Major Component, implement Standard Interface implementation available public source code form. “Major Component”, context, means major essential component (kernel, window system, ) specific operating system () executable work runs, compiler used produce work, object code interpreter used run . “Corresponding Source” work object code form means source code needed generate, install, (executable work) run object code modify work, including scripts control activities. However, include work’s System Libraries, general-purpose tools generally available free programs used unmodified performing activities part work. example, Corresponding Source includes interface definition files associated source files work, source code shared libraries dynamically linked subprograms work specifically designed require, intimate data communication control flow subprograms parts work. Corresponding Source need include anything users can regenerate automatically parts Corresponding Source. Corresponding Source work source code form work.","code":""},{"path":"/LICENSE.html","id":"id_2-basic-permissions","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"2. Basic Permissions","title":"GNU General Public License","text":"rights granted License granted term copyright Program, irrevocable provided stated conditions met. License explicitly affirms unlimited permission run unmodified Program. output running covered work covered License output, given content, constitutes covered work. License acknowledges rights fair use equivalent, provided copyright law. may make, run propagate covered works convey, without conditions long license otherwise remains force. may convey covered works others sole purpose make modifications exclusively , provide facilities running works, provided comply terms License conveying material control copyright. thus making running covered works must exclusively behalf, direction control, terms prohibit making copies copyrighted material outside relationship . Conveying circumstances permitted solely conditions stated . Sublicensing allowed; section 10 makes unnecessary.","code":""},{"path":"/LICENSE.html","id":"id_3-protecting-users-legal-rights-from-anti-circumvention-law","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"3. Protecting Users’ Legal Rights From Anti-Circumvention Law","title":"GNU General Public License","text":"covered work shall deemed part effective technological measure applicable law fulfilling obligations article 11 WIPO copyright treaty adopted 20 December 1996, similar laws prohibiting restricting circumvention measures. convey covered work, waive legal power forbid circumvention technological measures extent circumvention effected exercising rights License respect covered work, disclaim intention limit operation modification work means enforcing, work’s users, third parties’ legal rights forbid circumvention technological measures.","code":""},{"path":"/LICENSE.html","id":"id_4-conveying-verbatim-copies","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"4. Conveying Verbatim Copies","title":"GNU General Public License","text":"may convey verbatim copies Program’s source code receive , medium, provided conspicuously appropriately publish copy appropriate copyright notice; keep intact notices stating License non-permissive terms added accord section 7 apply code; keep intact notices absence warranty; give recipients copy License along Program. may charge price price copy convey, may offer support warranty protection fee.","code":""},{"path":"/LICENSE.html","id":"id_5-conveying-modified-source-versions","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"5. Conveying Modified Source Versions","title":"GNU General Public License","text":"may convey work based Program, modifications produce Program, form source code terms section 4, provided also meet conditions: ) work must carry prominent notices stating modified , giving relevant date. b) work must carry prominent notices stating released License conditions added section 7. requirement modifies requirement section 4 “keep intact notices”. c) must license entire work, whole, License anyone comes possession copy. License therefore apply, along applicable section 7 additional terms, whole work, parts, regardless packaged. License gives permission license work way, invalidate permission separately received . d) work interactive user interfaces, must display Appropriate Legal Notices; however, Program interactive interfaces display Appropriate Legal Notices, work need make . compilation covered work separate independent works, nature extensions covered work, combined form larger program, volume storage distribution medium, called “aggregate” compilation resulting copyright used limit access legal rights compilation’s users beyond individual works permit. Inclusion covered work aggregate cause License apply parts aggregate.","code":""},{"path":"/LICENSE.html","id":"id_6-conveying-non-source-forms","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"6. Conveying Non-Source Forms","title":"GNU General Public License","text":"may convey covered work object code form terms sections 4 5, provided also convey machine-readable Corresponding Source terms License, one ways: ) Convey object code , embodied , physical product (including physical distribution medium), accompanied Corresponding Source fixed durable physical medium customarily used software interchange. b) Convey object code , embodied , physical product (including physical distribution medium), accompanied written offer, valid least three years valid long offer spare parts customer support product model, give anyone possesses object code either (1) copy Corresponding Source software product covered License, durable physical medium customarily used software interchange, price reasonable cost physically performing conveying source, (2) access copy Corresponding Source network server charge. c) Convey individual copies object code copy written offer provide Corresponding Source. alternative allowed occasionally noncommercially, received object code offer, accord subsection 6b. d) Convey object code offering access designated place (gratis charge), offer equivalent access Corresponding Source way place charge. need require recipients copy Corresponding Source along object code. place copy object code network server, Corresponding Source may different server (operated third party) supports equivalent copying facilities, provided maintain clear directions next object code saying find Corresponding Source. Regardless server hosts Corresponding Source, remain obligated ensure available long needed satisfy requirements. e) Convey object code using peer--peer transmission, provided inform peers object code Corresponding Source work offered general public charge subsection 6d. separable portion object code, whose source code excluded Corresponding Source System Library, need included conveying object code work. “User Product” either (1) “consumer product”, means tangible personal property normally used personal, family, household purposes, (2) anything designed sold incorporation dwelling. determining whether product consumer product, doubtful cases shall resolved favor coverage. particular product received particular user, “normally used” refers typical common use class product, regardless status particular user way particular user actually uses, expects expected use, product. product consumer product regardless whether product substantial commercial, industrial non-consumer uses, unless uses represent significant mode use product. “Installation Information” User Product means methods, procedures, authorization keys, information required install execute modified versions covered work User Product modified version Corresponding Source. information must suffice ensure continued functioning modified object code case prevented interfered solely modification made. convey object code work section , , specifically use , User Product, conveying occurs part transaction right possession use User Product transferred recipient perpetuity fixed term (regardless transaction characterized), Corresponding Source conveyed section must accompanied Installation Information. requirement apply neither third party retains ability install modified object code User Product (example, work installed ROM). requirement provide Installation Information include requirement continue provide support service, warranty, updates work modified installed recipient, User Product modified installed. Access network may denied modification materially adversely affects operation network violates rules protocols communication across network. Corresponding Source conveyed, Installation Information provided, accord section must format publicly documented (implementation available public source code form), must require special password key unpacking, reading copying.","code":""},{"path":"/LICENSE.html","id":"id_7-additional-terms","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"7. Additional Terms","title":"GNU General Public License","text":"“Additional permissions” terms supplement terms License making exceptions one conditions. Additional permissions applicable entire Program shall treated though included License, extent valid applicable law. additional permissions apply part Program, part may used separately permissions, entire Program remains governed License without regard additional permissions. convey copy covered work, may option remove additional permissions copy, part . (Additional permissions may written require removal certain cases modify work.) may place additional permissions material, added covered work, can give appropriate copyright permission. Notwithstanding provision License, material add covered work, may (authorized copyright holders material) supplement terms License terms: ) Disclaiming warranty limiting liability differently terms sections 15 16 License; b) Requiring preservation specified reasonable legal notices author attributions material Appropriate Legal Notices displayed works containing ; c) Prohibiting misrepresentation origin material, requiring modified versions material marked reasonable ways different original version; d) Limiting use publicity purposes names licensors authors material; e) Declining grant rights trademark law use trade names, trademarks, service marks; f) Requiring indemnification licensors authors material anyone conveys material (modified versions ) contractual assumptions liability recipient, liability contractual assumptions directly impose licensors authors. non-permissive additional terms considered “restrictions” within meaning section 10. Program received , part , contains notice stating governed License along term restriction, may remove term. license document contains restriction permits relicensing conveying License, may add covered work material governed terms license document, provided restriction survive relicensing conveying. add terms covered work accord section, must place, relevant source files, statement additional terms apply files, notice indicating find applicable terms. Additional terms, permissive non-permissive, may stated form separately written license, stated exceptions; requirements apply either way.","code":""},{"path":"/LICENSE.html","id":"id_8-termination","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"8. Termination","title":"GNU General Public License","text":"may propagate modify covered work except expressly provided License. attempt otherwise propagate modify void, automatically terminate rights License (including patent licenses granted third paragraph section 11). However, cease violation License, license particular copyright holder reinstated () provisionally, unless copyright holder explicitly finally terminates license, (b) permanently, copyright holder fails notify violation reasonable means prior 60 days cessation. Moreover, license particular copyright holder reinstated permanently copyright holder notifies violation reasonable means, first time received notice violation License (work) copyright holder, cure violation prior 30 days receipt notice. Termination rights section terminate licenses parties received copies rights License. rights terminated permanently reinstated, qualify receive new licenses material section 10.","code":""},{"path":"/LICENSE.html","id":"id_9-acceptance-not-required-for-having-copies","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"9. Acceptance Not Required for Having Copies","title":"GNU General Public License","text":"required accept License order receive run copy Program. Ancillary propagation covered work occurring solely consequence using peer--peer transmission receive copy likewise require acceptance. However, nothing License grants permission propagate modify covered work. actions infringe copyright accept License. Therefore, modifying propagating covered work, indicate acceptance License .","code":""},{"path":"/LICENSE.html","id":"id_10-automatic-licensing-of-downstream-recipients","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"10. Automatic Licensing of Downstream Recipients","title":"GNU General Public License","text":"time convey covered work, recipient automatically receives license original licensors, run, modify propagate work, subject License. responsible enforcing compliance third parties License. “entity transaction” transaction transferring control organization, substantially assets one, subdividing organization, merging organizations. propagation covered work results entity transaction, party transaction receives copy work also receives whatever licenses work party’s predecessor interest give previous paragraph, plus right possession Corresponding Source work predecessor interest, predecessor can get reasonable efforts. may impose restrictions exercise rights granted affirmed License. example, may impose license fee, royalty, charge exercise rights granted License, may initiate litigation (including cross-claim counterclaim lawsuit) alleging patent claim infringed making, using, selling, offering sale, importing Program portion .","code":""},{"path":"/LICENSE.html","id":"id_11-patents","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"11. Patents","title":"GNU General Public License","text":"“contributor” copyright holder authorizes use License Program work Program based. work thus licensed called contributor’s “contributor version”. contributor’s “essential patent claims” patent claims owned controlled contributor, whether already acquired hereafter acquired, infringed manner, permitted License, making, using, selling contributor version, include claims infringed consequence modification contributor version. purposes definition, “control” includes right grant patent sublicenses manner consistent requirements License. contributor grants non-exclusive, worldwide, royalty-free patent license contributor’s essential patent claims, make, use, sell, offer sale, import otherwise run, modify propagate contents contributor version. following three paragraphs, “patent license” express agreement commitment, however denominated, enforce patent (express permission practice patent covenant sue patent infringement). “grant” patent license party means make agreement commitment enforce patent party. convey covered work, knowingly relying patent license, Corresponding Source work available anyone copy, free charge terms License, publicly available network server readily accessible means, must either (1) cause Corresponding Source available, (2) arrange deprive benefit patent license particular work, (3) arrange, manner consistent requirements License, extend patent license downstream recipients. “Knowingly relying” means actual knowledge , patent license, conveying covered work country, recipient’s use covered work country, infringe one identifiable patents country reason believe valid. , pursuant connection single transaction arrangement, convey, propagate procuring conveyance , covered work, grant patent license parties receiving covered work authorizing use, propagate, modify convey specific copy covered work, patent license grant automatically extended recipients covered work works based . patent license “discriminatory” include within scope coverage, prohibits exercise , conditioned non-exercise one rights specifically granted License. may convey covered work party arrangement third party business distributing software, make payment third party based extent activity conveying work, third party grants, parties receive covered work , discriminatory patent license () connection copies covered work conveyed (copies made copies), (b) primarily connection specific products compilations contain covered work, unless entered arrangement, patent license granted, prior 28 March 2007. Nothing License shall construed excluding limiting implied license defenses infringement may otherwise available applicable patent law.","code":""},{"path":"/LICENSE.html","id":"id_12-no-surrender-of-others-freedom","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"12. No Surrender of Others’ Freedom","title":"GNU General Public License","text":"conditions imposed (whether court order, agreement otherwise) contradict conditions License, excuse conditions License. convey covered work satisfy simultaneously obligations License pertinent obligations, consequence may convey . example, agree terms obligate collect royalty conveying convey Program, way satisfy terms License refrain entirely conveying Program.","code":""},{"path":"/LICENSE.html","id":"id_13-use-with-the-gnu-affero-general-public-license","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"13. Use with the GNU Affero General Public License","title":"GNU General Public License","text":"Notwithstanding provision License, permission link combine covered work work licensed version 3 GNU Affero General Public License single combined work, convey resulting work. terms License continue apply part covered work, special requirements GNU Affero General Public License, section 13, concerning interaction network apply combination .","code":""},{"path":"/LICENSE.html","id":"id_14-revised-versions-of-this-license","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"14. Revised Versions of this License","title":"GNU General Public License","text":"Free Software Foundation may publish revised /new versions GNU General Public License time time. new versions similar spirit present version, may differ detail address new problems concerns. version given distinguishing version number. Program specifies certain numbered version GNU General Public License “later version” applies , option following terms conditions either numbered version later version published Free Software Foundation. Program specify version number GNU General Public License, may choose version ever published Free Software Foundation. Program specifies proxy can decide future versions GNU General Public License can used, proxy’s public statement acceptance version permanently authorizes choose version Program. Later license versions may give additional different permissions. However, additional obligations imposed author copyright holder result choosing follow later version.","code":""},{"path":"/LICENSE.html","id":"id_15-disclaimer-of-warranty","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"15. Disclaimer of Warranty","title":"GNU General Public License","text":"WARRANTY PROGRAM, EXTENT PERMITTED APPLICABLE LAW. EXCEPT OTHERWISE STATED WRITING COPYRIGHT HOLDERS /PARTIES PROVIDE PROGRAM “” WITHOUT WARRANTY KIND, EITHER EXPRESSED IMPLIED, INCLUDING, LIMITED , IMPLIED WARRANTIES MERCHANTABILITY FITNESS PARTICULAR PURPOSE. ENTIRE RISK QUALITY PERFORMANCE PROGRAM . PROGRAM PROVE DEFECTIVE, ASSUME COST NECESSARY SERVICING, REPAIR CORRECTION.","code":""},{"path":"/LICENSE.html","id":"id_16-limitation-of-liability","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"16. Limitation of Liability","title":"GNU General Public License","text":"EVENT UNLESS REQUIRED APPLICABLE LAW AGREED WRITING COPYRIGHT HOLDER, PARTY MODIFIES /CONVEYS PROGRAM PERMITTED , LIABLE DAMAGES, INCLUDING GENERAL, SPECIAL, INCIDENTAL CONSEQUENTIAL DAMAGES ARISING USE INABILITY USE PROGRAM (INCLUDING LIMITED LOSS DATA DATA RENDERED INACCURATE LOSSES SUSTAINED THIRD PARTIES FAILURE PROGRAM OPERATE PROGRAMS), EVEN HOLDER PARTY ADVISED POSSIBILITY DAMAGES.","code":""},{"path":"/LICENSE.html","id":"id_17-interpretation-of-sections-15-and-16","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"17. Interpretation of Sections 15 and 16","title":"GNU General Public License","text":"disclaimer warranty limitation liability provided given local legal effect according terms, reviewing courts shall apply local law closely approximates absolute waiver civil liability connection Program, unless warranty assumption liability accompanies copy Program return fee. END TERMS CONDITIONS","code":""},{"path":"/LICENSE.html","id":"how-to-apply-these-terms-to-your-new-programs","dir":"","previous_headings":"","what":"How to Apply These Terms to Your New Programs","title":"GNU General Public License","text":"develop new program, want greatest possible use public, best way achieve make free software everyone can redistribute change terms. , attach following notices program. safest attach start source file effectively state exclusion warranty; file least “copyright” line pointer full notice found. Also add information contact electronic paper mail. program terminal interaction, make output short notice like starts interactive mode: hypothetical commands show w show c show appropriate parts General Public License. course, program’s commands might different; GUI interface, use “box”. also get employer (work programmer) school, , sign “copyright disclaimer” program, necessary. information , apply follow GNU GPL, see <http://www.gnu.org/licenses/>. GNU General Public License permit incorporating program proprietary programs. program subroutine library, may consider useful permit linking proprietary applications library. want , use GNU Lesser General Public License instead License. first, please read <http://www.gnu.org/philosophy/--lgpl.html>.","code":"<one line to give the program's name and a brief idea of what it does.> Copyright (C) <year>  <name of author>  This program is free software: you can redistribute it and/or modify it under the terms of the GNU General Public License as published by the Free Software Foundation, either version 3 of the License, or (at your option) any later version.  This program is distributed in the hope that it will be useful, but WITHOUT ANY WARRANTY; without even the implied warranty of MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE.  See the GNU General Public License for more details.  You should have received a copy of the GNU General Public License along with this program.  If not, see <http://www.gnu.org/licenses/>. <program>  Copyright (C) <year>  <name of author> This program comes with ABSOLUTELY NO WARRANTY; for details type 'show w'. This is free software, and you are welcome to redistribute it under certain conditions; type 'show c' for details."},{"path":"/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Benedikt Claus. Author, maintainer.","code":""},{"path":"/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Claus B (2023). clinicalsignificance: Toolbox Clinical Significance Analyses Intervention Studies. https://pedscience.github.io/clinicalsignificance/, https://github.com/pedscience/clinicalsignificance.","code":"@Manual{,   title = {clinicalsignificance: A Toolbox for Clinical Significance Analyses in Intervention Studies},   author = {Benedikt Claus},   year = {2023},   note = {https://pedscience.github.io/clinicalsignificance/, https://github.com/pedscience/clinicalsignificance}, }"},{"path":"/index.html","id":"clinicalsignificance-","dir":"","previous_headings":"","what":"An R-Package for Clinical Significance Analyses","title":"An R-Package for Clinical Significance Analyses","text":"goal package provide necessary tools analyses clinical significance clinical intervention studies. contrast statistical significance, assesses probable treatment effect, clinical significance can used determine treatment effect practical use meaningful patients.","code":""},{"path":"/index.html","id":"installation","dir":"","previous_headings":"","what":"Installation","title":"An R-Package for Clinical Significance Analyses","text":"can install clinicalsignificance CRAN development version GitHub:","code":"install.packages(\"clinicalsignificance\")  # Or you install the development version from GitHub: # install.packages(\"devtools\") devtools::install_github(\"pedscience/clinicalsignificance\")"},{"path":"/index.html","id":"example","dir":"","previous_headings":"","what":"Example","title":"An R-Package for Clinical Significance Analyses","text":"Given tidy dataset, employed instrument’s reliability minimal important difference instrument, clinical significance analysis can calculated following function call. can receive detailed summary analysis plot results ","code":"library(clinicalsignificance)  results <- claus_2020 |>   cs_anchor(     id = id,     time = time,     outcome = bdi,     pre = 1,     post = 4,     mid_improvement = 7   )  results #>  #> ── Clinical Significance Results ── #>  #> Individual anchor-based approach with a 7 point decrease in instrument scores #> indicating a clinical significant improvement. #> Category     |  n | Percent #> --------------------------- #> Improved     | 25 |    0.62 #> Unchanged    | 11 |    0.28 #> Deteriorated |  4 |    0.10 summary(results) #>  #> ── Clinical Significance Results ── #>  #> Individual anchor-based analysis of clinical significance with a 7 point #> decrease in instrument scores (bdi) indicating a clinical significant #> improvement. #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> ── Individual Level Results #> Category     |  n | Percent #> --------------------------- #> Improved     | 25 |    0.62 #> Unchanged    | 11 |    0.28 #> Deteriorated |  4 |    0.10 plot(results)"},{"path":"/reference/antidepressants.html","id":null,"dir":"Reference","previous_headings":"","what":"Antidepressant Data — antidepressants","title":"Antidepressant Data — antidepressants","text":"fictional dataset used showcase group-based clinical significance analyses analyses many participants.","code":""},{"path":"/reference/antidepressants.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Antidepressant Data — antidepressants","text":"","code":"antidepressants"},{"path":"/reference/antidepressants.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Antidepressant Data — antidepressants","text":"tibble 1140 rows 4 variables: patient Patient identifier condition Experimental condition measurement Indicator measurement mom_di Mind Mood Depression inventory scores (lower better)","code":""},{"path":"/reference/antidepressants.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Antidepressant Data — antidepressants","text":"fictional clinical trial, effectiveness new antidepressant examined depressed patients randomized one four groups: wait list control group receive medication inactive placebo group, .e., group received placebo (inert substance without proposed clinical effect) pill active placebo group, .e., group received placebo evokes side effects like mild nausea dry mouth antidepressant group, target medication trial clinical impact patients' depressive symptoms Suppose underwent outpatient treatment, depressive symptoms measured treatment Mind Mood Depression Inventory (MoM-DI) Greenberger & Padesky (2015), patient received pill, clinician patient know, type medicaction consumed. , minimal important difference improvement measured instrument agreed 8 point decrease. deterioration can assumed instrument scores increased 5 points. functional population (.e., non-depressed individuals) can expected mean score M = 8 points standard deviation SD = 7.","code":""},{"path":"/reference/antidepressants.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Antidepressant Data — antidepressants","text":"Greenberger, D., & Padesky, C. . (2015). Mind mood, second edition (2nd ed.). New York, NY: Guilford Publications.","code":""},{"path":"/reference/anxiety.html","id":null,"dir":"Reference","previous_headings":"","what":"Anxiety Data — anxiety","title":"Anxiety Data — anxiety","text":"fictional dataset missings exemplify use HLM method clinical significance.","code":""},{"path":"/reference/anxiety.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Anxiety Data — anxiety","text":"","code":"anxiety"},{"path":"/reference/anxiety.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Anxiety Data — anxiety","text":"data frame 580 rows 4 variables: subject Participant treatment Treatment. Either Placebo Intervention measurement Number measurement anxiety Anxiety score (lower better)","code":""},{"path":"/reference/anxiety.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Anxiety Data — anxiety","text":"fictional clinical trial, participants split belong either medical placebo (\"Placebo\") psychotherapeutic intervention (\"Intervention\") group. underwent outpatient treatment followed 5 measurements fictional anxiety score measured. anxiety score may range 0 - 60. functional population (.e., non-anxious individuals) can expected mean score M = 8 points standard deviation SD = 4.","code":""},{"path":"/reference/anxiety_complete.html","id":null,"dir":"Reference","previous_headings":"","what":"Anxiety Data (Complete) — anxiety_complete","title":"Anxiety Data (Complete) — anxiety_complete","text":"fictional complete dataset exemplify use HLM method clinical significance.","code":""},{"path":"/reference/anxiety_complete.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Anxiety Data (Complete) — anxiety_complete","text":"","code":"anxiety_complete"},{"path":"/reference/anxiety_complete.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Anxiety Data (Complete) — anxiety_complete","text":"data frame 580 rows 4 variables: subject Participant treatment Treatment. Either Placebo Intervention measurement Number measurement anxiety Anxiety score (lower better)","code":""},{"path":"/reference/anxiety_complete.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Anxiety Data (Complete) — anxiety_complete","text":"fictional clinical trial, participants split belong either medical placebo (\"Placebo\") psychotherapeutic intervention (\"Intervention\") group. underwent outpatient treatment followed 5 measurements fictional anxiety score measured. anxiety score may range 0 - 60. functional population (.e., non-anxious individuals) can expected mean score M = 8 points standard deviation SD = 4.","code":""},{"path":"/reference/augmented_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Extract Augmented Data from a cs_analysis Object — cs_get_augmented_data","title":"Extract Augmented Data from a cs_analysis Object — cs_get_augmented_data","text":"function returns patient-wise results, containing considered pre post intervention value, raw change well change estimates calculated clinical significance analysis individual's clinical significance category. function useful individual level analyses group level analyses yield group level results.","code":""},{"path":"/reference/augmented_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Extract Augmented Data from a cs_analysis Object — cs_get_augmented_data","text":"","code":"cs_get_augmented_data(x, ...)  # S3 method for default cs_get_augmented_data(x, ...)  # S3 method for cs_distribution cs_get_augmented_data(x, ...)  # S3 method for cs_statistical cs_get_augmented_data(x, ...)  # S3 method for cs_combined cs_get_augmented_data(x, ...)  # S3 method for cs_percentage cs_get_augmented_data(x, ...)  # S3 method for cs_anchor_individual_within cs_get_augmented_data(x, ...)"},{"path":"/reference/augmented_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Extract Augmented Data from a cs_analysis Object — cs_get_augmented_data","text":"x cs_analysis object ... Additional arguments","code":""},{"path":"/reference/augmented_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Extract Augmented Data from a cs_analysis Object — cs_get_augmented_data","text":"tibble augmented data","code":""},{"path":[]},{"path":"/reference/augmented_data.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Extract Augmented Data from a cs_analysis Object — cs_get_augmented_data","text":"","code":"# Augmented data can be extracted for every individual approach anchor_results <- claus_2020 |>   cs_anchor(     id,     time,     bdi,     pre = 1,     post = 4,     mid_improvement = 9   )   distribution_results <- claus_2020 |>   cs_distribution(     id,     time,     bdi,     pre = 1,     post = 4,     reliability = 0.80   )   distribution_results_hlm <- claus_2020 |>   cs_distribution(     id,     time,     bdi,     rci_method = \"HLM\"   )   statistical_results <- claus_2020 |>   cs_statistical(     id,     time,     bdi,     pre = 1,     post = 4,     m_functional = 8,     sd_functional = 8   )   combined_results <- claus_2020 |>   cs_combined(     id,     time,     bdi,     pre = 1,     post = 4,     m_functional = 8,     sd_functional = 8,     reliability = 0.80   )   cs_get_augmented_data(anchor_results) #> # A tibble: 40 × 8 #>       id   pre  post change improved deteriorated unchanged category  #>    <dbl> <dbl> <dbl>  <dbl> <lgl>    <lgl>        <lgl>     <fct>     #>  1     1    33    27     -6 FALSE    FALSE        TRUE      Unchanged #>  2     2    26    19     -7 FALSE    FALSE        TRUE      Unchanged #>  3     3    15     5    -10 TRUE     FALSE        FALSE     Improved  #>  4     5    39    46      7 FALSE    FALSE        TRUE      Unchanged #>  5     6    22    28      6 FALSE    FALSE        TRUE      Unchanged #>  6     7    25    18     -7 FALSE    FALSE        TRUE      Unchanged #>  7     8    33    30     -3 FALSE    FALSE        TRUE      Unchanged #>  8     9    23     8    -15 TRUE     FALSE        FALSE     Improved  #>  9    10    47    24    -23 TRUE     FALSE        FALSE     Improved  #> 10    11    43    13    -30 TRUE     FALSE        FALSE     Improved  #> # ℹ 30 more rows cs_get_augmented_data(distribution_results) #> # A tibble: 40 × 9 #>       id   pre  post change    rci improved deteriorated unchanged category  #>    <dbl> <dbl> <dbl>  <dbl>  <dbl> <lgl>    <lgl>        <lgl>     <fct>     #>  1     1    33    27     -6 -1.16  FALSE    FALSE        TRUE      Unchanged #>  2     2    26    19     -7 -1.36  FALSE    FALSE        TRUE      Unchanged #>  3     3    15     5    -10 -1.94  FALSE    FALSE        TRUE      Unchanged #>  4     5    39    46      7  1.36  FALSE    FALSE        TRUE      Unchanged #>  5     6    22    28      6  1.16  FALSE    FALSE        TRUE      Unchanged #>  6     7    25    18     -7 -1.36  FALSE    FALSE        TRUE      Unchanged #>  7     8    33    30     -3 -0.581 FALSE    FALSE        TRUE      Unchanged #>  8     9    23     8    -15 -2.91  TRUE     FALSE        FALSE     Improved  #>  9    10    47    24    -23 -4.46  TRUE     FALSE        FALSE     Improved  #> 10    11    43    13    -30 -5.81  TRUE     FALSE        FALSE     Improved  #> # ℹ 30 more rows cs_get_augmented_data(distribution_results_hlm) #> # A tibble: 40 × 9 #>    id        n   pre  post     rci improved deteriorated unchanged category     #>    <chr> <int> <dbl> <dbl>   <dbl> <lgl>    <lgl>        <lgl>     <fct>        #>  1 1         4    33    27  0.422  FALSE    FALSE        TRUE      Unchanged    #>  2 2         4    26    19 -0.0659 FALSE    FALSE        TRUE      Unchanged    #>  3 3         4    15     5 -1.46   FALSE    FALSE        TRUE      Unchanged    #>  4 5         4    39    46  2.61   FALSE    TRUE         FALSE     Deteriorated #>  5 6         4    22    28  1.13   FALSE    FALSE        TRUE      Unchanged    #>  6 7         4    25    18 -0.340  FALSE    FALSE        TRUE      Unchanged    #>  7 8         4    33    30  0.774  FALSE    FALSE        TRUE      Unchanged    #>  8 9         4    23     8 -1.64   FALSE    FALSE        TRUE      Unchanged    #>  9 10        4    47    24 -0.572  FALSE    FALSE        TRUE      Unchanged    #> 10 11        4    43    13 -2.11   TRUE     FALSE        FALSE     Improved     #> # ℹ 30 more rows cs_get_augmented_data(statistical_results) #> # A tibble: 40 × 7 #>       id   pre  post change clinical_pre functional_post category  #>    <dbl> <dbl> <dbl>  <dbl> <lgl>        <lgl>           <fct>     #>  1     1    33    27     -6 TRUE         FALSE           Unchanged #>  2     2    26    19     -7 TRUE         TRUE            Improved  #>  3     3    15     5    -10 FALSE        TRUE            Unchanged #>  4     5    39    46      7 TRUE         FALSE           Unchanged #>  5     6    22    28      6 TRUE         FALSE           Unchanged #>  6     7    25    18     -7 TRUE         TRUE            Improved  #>  7     8    33    30     -3 TRUE         FALSE           Unchanged #>  8     9    23     8    -15 TRUE         TRUE            Improved  #>  9    10    47    24    -23 TRUE         FALSE           Unchanged #> 10    11    43    13    -30 TRUE         TRUE            Improved  #> # ℹ 30 more rows cs_get_augmented_data(combined_results) #> # A tibble: 40 × 11 #>       id   pre  post change    rci recovered improved unchanged deteriorated #>    <dbl> <dbl> <dbl>  <dbl>  <dbl> <lgl>     <lgl>    <lgl>     <lgl>        #>  1     1    33    27     -6 -1.16  FALSE     FALSE    TRUE      FALSE        #>  2     2    26    19     -7 -1.36  FALSE     FALSE    TRUE      FALSE        #>  3     3    15     5    -10 -1.94  FALSE     FALSE    TRUE      FALSE        #>  4     5    39    46      7  1.36  FALSE     FALSE    TRUE      FALSE        #>  5     6    22    28      6  1.16  FALSE     FALSE    TRUE      FALSE        #>  6     7    25    18     -7 -1.36  FALSE     FALSE    TRUE      FALSE        #>  7     8    33    30     -3 -0.581 FALSE     FALSE    TRUE      FALSE        #>  8     9    23     8    -15 -2.91  TRUE      FALSE    FALSE     FALSE        #>  9    10    47    24    -23 -4.46  FALSE     TRUE     FALSE     FALSE        #> 10    11    43    13    -30 -5.81  TRUE      FALSE    FALSE     FALSE        #> # ℹ 30 more rows #> # ℹ 2 more variables: harmed <lgl>, category <fct>"},{"path":"/reference/calc_anchor.html","id":null,"dir":"Reference","previous_headings":"","what":"Generic to Calculate Anchor-Based Results — calc_anchor","title":"Generic to Calculate Anchor-Based Results — calc_anchor","text":"internal generic called directly. Depending different anchor method requested user, appropriate method called. calculates change according clinical significance category participant. internal function never called directly.","code":""},{"path":"/reference/calc_anchor.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Generic to Calculate Anchor-Based Results — calc_anchor","text":"","code":"calc_anchor(data, ...)  # S3 method for cs_anchor_individual_within calc_anchor(data, mid_improvement, mid_deterioration, direction, ci_level, ...)  # S3 method for cs_anchor_group_within calc_anchor(   data,   mid_improvement,   mid_deterioration,   direction,   ci_level,   bayesian,   prior_scale,   ... )  # S3 method for cs_anchor_group_between calc_anchor(   data,   mid_improvement,   mid_deterioration,   reference_group,   post,   direction,   ci_level,   bayesian,   prior_scale,   ... )"},{"path":"/reference/calc_anchor.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Generic to Calculate Anchor-Based Results — calc_anchor","text":"data data set object class cs_* ... Additional arguments mid_improvement Numeric, change indicates clinically significant improvement mid_deterioration Numeric, change indicates clinically significant deterioration direction direction beneficial? Lower = -1, better = 1 ci_level Numeric, desired confidence interval. bayesian Logical, Bayesian tests uncertainty intervals used, defaults TRUE. prior_scale String numeric, can adjusted change Bayesian prior distribution. See documentation rscale BayesFactor::ttestBF() details reference_group String, reference group compare groups post measurement groups compared, typically measurement intervention.","code":""},{"path":"/reference/calc_anchor.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Generic to Calculate Anchor-Based Results — calc_anchor","text":"object class cs_anchor_*","code":""},{"path":"/reference/calc_cutoff.html","id":null,"dir":"Reference","previous_headings":"","what":"Generic for Statistical Approach — calc_cutoff_from_data","title":"Generic for Statistical Approach — calc_cutoff_from_data","text":"internal generic called directly. Depending different cutoff method requested user, appropriate method called. calculates cutoff according clinical significance category participant.","code":""},{"path":"/reference/calc_cutoff.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Generic for Statistical Approach — calc_cutoff_from_data","text":"","code":"calc_cutoff_from_data(data, ...)  # S3 method for default calc_cutoff_from_data(   data,   m_clinical,   sd_clinical,   m_functional,   sd_functional,   type = \"a\",   direction = 1,   ... )  # S3 method for cs_ha calc_cutoff_from_data(   data,   m_clinical,   sd_clinical,   m_functional,   sd_functional,   m_post,   sd_post,   reliability,   type = \"a\",   direction = 1,   critical_value = 1.65,   ... )"},{"path":"/reference/calc_cutoff.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Generic for Statistical Approach — calc_cutoff_from_data","text":"data pre-processed wide data frame least column id, pre post class cs_* ... Additional arguments respective cutoff method m_clinical Mean clinical population sd_clinical SD clinical population m_functional Mean functional population sd_functional SD functional population type Cutoff type, available \"\", \"b\", \"c\" direction Beneficial intervention effect given instrument. 1 = higher better, -1 = lower better m_post Mean post measurement sd_post SD post measurement reliability Instrument's reliability critical_value critical value RCI decision, 1.65 significance_level = 0.05","code":""},{"path":"/reference/calc_cutoff.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Generic for Statistical Approach — calc_cutoff_from_data","text":"list cutoff info participant wise info cutoff categorization","code":""},{"path":"/reference/calc_percentage.html","id":null,"dir":"Reference","previous_headings":"","what":"Calculate Change for the Percentage-Change Approach — calc_percentage","title":"Calculate Change for the Percentage-Change Approach — calc_percentage","text":"internal generic called directly. Depending different percent change cutoff requested user, function calculates relative change according clinical significance category patient.","code":""},{"path":"/reference/calc_percentage.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Calculate Change for the Percentage-Change Approach — calc_percentage","text":"","code":"calc_percentage(data, pct_improvement, pct_deterioration, direction)"},{"path":"/reference/calc_percentage.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Calculate Change for the Percentage-Change Approach — calc_percentage","text":"data pre-processed data frame least columns change pre pct_improvement Numeric, required percent change cutoff infer improvement pct_deterioration Numeric, required percent change cutoff infer deterioration direction Beneficial intervention effect given instrument. 1 = higher better, -1 = lower better","code":""},{"path":"/reference/calc_percentage.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Calculate Change for the Percentage-Change Approach — calc_percentage","text":"object classm cs_percentage list participant-wise info clinical significant change catergory","code":""},{"path":"/reference/calc_rci.html","id":null,"dir":"Reference","previous_headings":"","what":"Generic to Calculate RCI and Associated Change — calc_rci","title":"Generic to Calculate RCI and Associated Change — calc_rci","text":"internal generic called directly. Depending different RCI method requested user, appropriate method called. calculates RCI according clinical significance category participant.","code":""},{"path":"/reference/calc_rci.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Generic to Calculate RCI and Associated Change — calc_rci","text":"","code":"calc_rci(data, ...)  # S3 method for cs_jt calc_rci(data, sd_pre, reliability, direction = 1, critical_value = 1.96, ...)  # S3 method for cs_gln calc_rci(   data,   m_pre,   sd_pre,   reliability,   direction = 1,   critical_value = 1.96,   ... )  # S3 method for cs_hll calc_rci(   data,   m_pre,   sd_pre,   m_post,   reliability,   direction = 1,   critical_value = 1.96,   ... )  # S3 method for cs_en calc_rci(   data,   m_pre,   sd_pre,   reliability,   direction = 1,   critical_value = 1.96,   ... )  # S3 method for cs_nk calc_rci(   data,   m_pre,   sd_pre,   reliability,   reliability_post,   direction = 1,   critical_value = 1.96,   ... )  # S3 method for cs_ha calc_rci(   data,   m_pre,   sd_pre,   m_post,   sd_post,   reliability,   direction = 1,   critical_value = 1.65,   ... )  # S3 method for cs_hlm calc_rci(data, direction, critical_value = 1.96, ...)"},{"path":"/reference/calc_rci.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Generic to Calculate RCI and Associated Change — calc_rci","text":"data Prepped data class cs_* ... Additional arguments specific RCI method sd_pre Pre measurement SD reliability Instrument reliability direction Beneficial intervention effect given instrument. 1 = higher better, -1 = lower better critical_value Critical RCI value, typically 1.96 m_pre Pre measurement mean m_post Post measurement mean reliability_post Instrument reliability post measurement sd_post Post measurement SD","code":""},{"path":"/reference/calc_rci.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Generic to Calculate RCI and Associated Change — calc_rci","text":"RCI result object class cs_distribution","code":""},{"path":"/reference/claus_2020.html","id":null,"dir":"Reference","previous_headings":"","what":"Placebo Amplification Data — claus_2020","title":"Placebo Amplification Data — claus_2020","text":"dataset containing data Claus et al. (2020). routine inpatient setting unipolar depressive disorders implemented intervention sought amplify placebo response antidepressants. study, two groups compared: treatment usual (TAU) placebo amplification (PA). Participants examined four times treatment.","code":""},{"path":"/reference/claus_2020.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Placebo Amplification Data — claus_2020","text":"","code":"claus_2020"},{"path":"/reference/claus_2020.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Placebo Amplification Data — claus_2020","text":"object class tbl_df 172 rows 9 columns. id Participant ID age Age sex Sex treatment Treatment (TAU treatment usual PA placebo amplification) time Measurement bdi Beck Depression Inventory (2nd Edition) score (lower better) shaps Snaith-Hamilton Pleasure Scale score (higher better) -Five Well-Index score (higher better) hamd Hamilton Rating Scale Depression score (lower better)","code":""},{"path":"/reference/claus_2020.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Placebo Amplification Data — claus_2020","text":"https://osf.io/rc754/","code":""},{"path":"/reference/claus_2020.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Placebo Amplification Data — claus_2020","text":"Claus, B. B., Scherbaum, N., & Bonnet, U. (2020). Effectiveness Adjunctive Psychotherapeutic Intervention Developed Enhancing Placebo Effect Antidepressants Used within Inpatient-Treatment Program Major Depression: Pragmatic Parallel-Group, Randomized Controlled Trial. Psychotherapy Psychosomatics, 89(4), 258-260. https://doi.org/10.1159/000505855","code":""},{"path":"/reference/create_summary.html","id":null,"dir":"Reference","previous_headings":"","what":"Generic For Creating Summary Tables — create_summary_table","title":"Generic For Creating Summary Tables — create_summary_table","text":"internal function used create summary table different clinical significance methods. used directly.","code":""},{"path":"/reference/create_summary.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Generic For Creating Summary Tables — create_summary_table","text":"","code":"create_summary_table(x, ...)  # S3 method for cs_distribution create_summary_table(x, data, ...)  # S3 method for cs_statistical create_summary_table(x, data, method, ...)  # S3 method for cs_combined create_summary_table(   x,   cutoff_results,   data,   method,   r_dd,   se_measurement,   cutoff,   sd_post,   direction,   ... )  # S3 method for cs_percentage create_summary_table(x, data, ...)  # S3 method for cs_anchor_individual_within create_summary_table(x, data, ...)"},{"path":"/reference/create_summary.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Generic For Creating Summary Tables — create_summary_table","text":"x results object differs per approach: RCI results distribution-based combined approach Cutoff results statistical approach PCT results percentage-change approach Anchor results anchor-based approach ... Additional arguments data used data frame method Clinical significance method cutoff_results Cutoff results object r_dd r_dd se_measurement se_measurement cutoff Cutoff value sd_post SD post intervention direction direction beneficial? 1 = higher, -1 = lower","code":""},{"path":"/reference/create_summary.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Generic For Creating Summary Tables — create_summary_table","text":"tibble","code":""},{"path":"/reference/cs_anchor.html","id":null,"dir":"Reference","previous_headings":"","what":"Anchor-Based Analysis of Clinical Significance — cs_anchor","title":"Anchor-Based Analysis of Clinical Significance — cs_anchor","text":"cs_anchor() can used determine clinical significance intervention studies employing anchor-based approach. , predefined minimally important difference (MID) instrument known corresponds important symptom improvement patients. data can analyzed individual well group level estimate, change intervention clinically significant.","code":""},{"path":"/reference/cs_anchor.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Anchor-Based Analysis of Clinical Significance — cs_anchor","text":"","code":"cs_anchor(   data,   id,   time,   outcome,   group,   pre = NULL,   post = NULL,   mid_improvement = NULL,   mid_deterioration = NULL,   better_is = c(\"lower\", \"higher\"),   target = c(\"individual\", \"group\"),   effect = c(\"within\", \"between\"),   bayesian = TRUE,   prior_scale = \"medium\",   reference_group = NULL,   ci_level = 0.95 )"},{"path":"/reference/cs_anchor.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Anchor-Based Analysis of Clinical Significance — cs_anchor","text":"data tidy data frame id Participant ID time Time variable outcome Outcome variable group Grouping variable (optional) pre Pre measurement (needed time variable contains two measurements) post Post measurement (needed time variable contains two measurements) mid_improvement Numeric, change indicates clinically significant improvement mid_deterioration Numeric, change indicates clinically significant deterioration (optional). mid_deterioration provided, assumed equal mid_improvement better_is direction means better outcome used instrument? Available \"lower\" (lower outcome scores desirable, default) \"higher\" (higher outcome scores desirable) target String, whether individual group analysis calculated. Available \"individual\" (default) every individual participant evaluated \"group\" group wise effect evaluated effect String, target = \"group\", specify effect calculated. Available \"within\" (default), yields mean pre-post intervention difference associated confidence intervals \"\", estimates group wise mean difference confidence intervals two groups specified group argument specified measurement supplied post- argument reference group may supplied reference_group bayesian Logical, relevant target = \"group\". Indicates Bayesian estimate (.e., median) group differences credible interval calculated (set TRUE, default) frequentist mean difference confidence interval (set FALSE) prior_scale String numeric, can adjusted change Bayesian prior distribution. See documentation rscale BayesFactor::ttestBF() details. reference_group Specify reference group subsequent groups compared target = \"group\" effect = \"within\" (optional). Otherwise, first distinct group chosen based alphabetical, numerical factor ordering. ci_level Numeric, define credible confidence interval level. default 0.95 95%-CI.","code":""},{"path":"/reference/cs_anchor.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Anchor-Based Analysis of Clinical Significance — cs_anchor","text":"S3 object class cs_analysis cs_anchor","code":""},{"path":"/reference/cs_anchor.html","id":"computational-details","dir":"Reference","previous_headings":"","what":"Computational details","title":"Anchor-Based Analysis of Clinical Significance — cs_anchor","text":"individual-level analyses, analysis straight forward. MID can specified improvement well deterioration (must necessarily identical) function basically counts many patients fall within MID range , improvement deterioration, many patients exceed limits range either direction. patient may categorized : Improved, patient demonstrated change equal greater MID improvement Unchanged, patient demonstrated change less MIDs Deteriorated, patient demonstrated change equal greater MID deterioration group-level analyses, whole sample either treated single group split grouping presented data. within group analyses, function calculates median change pre post intervention associated credible interval (CI). Based median change limits CI, group change can categorized 5 distinctive categories: Statistically significant, CI contains 0 Statistically significant clinically relevant, CI contain 0, median CI limits beneath MID threshold significantly less threshold, MID threshold falls within CI median still threshold Probably clinically significant effect, median crossed MID threshold threshold still inside CI Large clinically significant effect, median crossed MID threshold CI contain threshold group comparison desired, reference group can defined reference_group argument subsequent groups compared. usually inactive comparator placebo wait-list control group. difference pairwise compared groups categorized just within group difference , categories apply. approach can changed classical frequentist framework point estimate represents mean difference CI confidence interval. extensive overview differences Bayesian frequentist CI, refer Hespanhol et al. (2019).","code":""},{"path":"/reference/cs_anchor.html","id":"data-preparation","dir":"Reference","previous_headings":"","what":"Data preparation","title":"Anchor-Based Analysis of Clinical Significance — cs_anchor","text":"data set must tidy, corresponds long data frame general. must contain patient identifier must unique per patient. Also, column containing different measurements outcome must supplied. participant-measurement combination must unique, instance, data must contain two \"\" measurements patient. Additionally, measurement column contains two values, first value based alphabetical, numerical factor ordering used pre measurement. instance, column contains measurements identifiers \"pre\" \"post\" strings, \"post\" sorted \"pre\" thus used \"pre\" measurement. function throw warning generally may want explicitly define \"pre\" \"post\" measurement arguments pre post. case two measurement identifiers, define pre post manually since function know pre post intervention measurements . data grouped, can specify group referencing grouping variable (see examples ). analysis run every group compare group differences.","code":""},{"path":"/reference/cs_anchor.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Anchor-Based Analysis of Clinical Significance — cs_anchor","text":"Hespanhol, L., Vallio, C. S., Costa, L. M., & Saragiotto, B. T. (2019). Understanding interpreting confidence credible intervals around effect estimates. Brazilian Journal Physical Therapy, 23(4), 290–301. https://doi.org/10.1016/j.bjpt.2018.12.006","code":""},{"path":[]},{"path":"/reference/cs_anchor.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Anchor-Based Analysis of Clinical Significance — cs_anchor","text":"","code":"cs_results <- antidepressants |>   cs_anchor(patient, measurement, mom_di, mid_improvement = 8) #> ℹ Your \"Before\" was set as pre measurement and and your \"After\" as post. #> • If that is not correct, please specify the pre measurement with the argument #>   \"pre\".  cs_results #>  #> ── Clinical Significance Results ── #>  #> Individual anchor-based approach with a 8 point decrease in instrument scores #> indicating a clinical significant improvement. #>  #> Category     |   n | Percent #> ---------------------------- #> Improved     | 316 |    0.57 #> Unchanged    | 175 |    0.32 #> Deteriorated |  64 |    0.12 plot(cs_results)   # Set argument \"pre\" to avoid a warning cs_results <- antidepressants |>   cs_anchor(     patient,     measurement,     mom_di,     pre = \"Before\",     mid_improvement = 8   )   # Inlcude the MID for deterioration cs_results_with_deterioration <- antidepressants |>   cs_anchor(     patient,     measurement,     mom_di,     pre = \"Before\",     mid_improvement = 8,     mid_deterioration = 5   )  cs_results_with_deterioration #>  #> ── Clinical Significance Results ── #>  #> Individual anchor-based approach with a 8 point decrease in instrument scores #> indicating a clinical significant improvement and a 5 point increase in #> instrument scores indicating a clinical significant deterioration. #>  #> Category     |   n | Percent #> ---------------------------- #> Improved     | 316 |    0.57 #> Unchanged    | 152 |    0.27 #> Deteriorated |  87 |    0.16 summary(cs_results_with_deterioration) #>  #> ── Clinical Significance Results ── #>  #> Individual anchor-based analysis of clinical significance with a 8 point #> decrease in instrument scores (mom_di) indicating a clinical significant #> improvement and a 5 point increase in instrument scores indicating a clinical #> significant deterioration. #>  #> There were 555 participants in the whole dataset of which 555 (100%) could be #> included in the analysis. #>  #>  #> ── Individual Level Results  #>  #> Category     |   n | Percent #> ---------------------------- #> Improved     | 316 |    0.57 #> Unchanged    | 152 |    0.27 #> Deteriorated |  87 |    0.16 plot(cs_results_with_deterioration)    # Group the results by experimental condition cs_results_grouped <- antidepressants |>   cs_anchor(     patient,     measurement,     mom_di,     pre = \"Before\",     group = condition,     mid_improvement = 8,     mid_deterioration = 5   )  cs_results_grouped #>  #> ── Clinical Significance Results ── #>  #> Individual anchor-based approach with a 8 point decrease in instrument scores #> indicating a clinical significant improvement and a 5 point increase in #> instrument scores indicating a clinical significant deterioration. #>  #> Group            |     Category |   n |  Percent #> ------------------------------------------------ #> Wait List        |     Improved |  27 |     0.05 #> Wait List        |    Unchanged |  65 |     0.12 #> Wait List        | Deteriorated |  60 |     0.11 #> Inactive Placebo |     Improved |  71 |     0.13 #> Inactive Placebo |    Unchanged |  41 |     0.07 #> Inactive Placebo | Deteriorated |  18 |     0.03 #> Active Placebo   |     Improved |  98 |     0.18 #> Active Placebo   |    Unchanged |  20 |     0.04 #> Active Placebo   | Deteriorated |   3 | 5.41e-03 #> Antidepressant   |     Improved | 120 |     0.22 #> Antidepressant   |    Unchanged |  26 |     0.05 #> Antidepressant   | Deteriorated |   6 |     0.01 summary(cs_results_grouped) #>  #> ── Clinical Significance Results ── #>  #> Individual anchor-based analysis of clinical significance with a 8 point #> decrease in instrument scores (mom_di) indicating a clinical significant #> improvement and a 5 point increase in instrument scores indicating a clinical #> significant deterioration. #>  #> There were 555 participants in the whole dataset of which 555 (100%) could be #> included in the analysis. #>  #>  #> ── Individual Level Results  #>  #> Group            |     Category |   n |  Percent #> ------------------------------------------------ #> Wait List        |     Improved |  27 |     0.05 #> Wait List        |    Unchanged |  65 |     0.12 #> Wait List        | Deteriorated |  60 |     0.11 #> Inactive Placebo |     Improved |  71 |     0.13 #> Inactive Placebo |    Unchanged |  41 |     0.07 #> Inactive Placebo | Deteriorated |  18 |     0.03 #> Active Placebo   |     Improved |  98 |     0.18 #> Active Placebo   |    Unchanged |  20 |     0.04 #> Active Placebo   | Deteriorated |   3 | 5.41e-03 #> Antidepressant   |     Improved | 120 |     0.22 #> Antidepressant   |    Unchanged |  26 |     0.05 #> Antidepressant   | Deteriorated |   6 |     0.01 plot(cs_results_grouped)   # The plot method always returns a ggplot2 object, so the plot may be further # modified with ggplot2 code, e.g., facetting to avoid overplotting of groups plot(cs_results_grouped) +   ggplot2::facet_wrap(~ group)    # Compute group wise results cs_results_groupwise <- antidepressants |>   cs_anchor(     patient,     measurement,     mom_di,     pre = \"Before\",     mid_improvement = 8,     target = \"group\"   )  cs_results_groupwise #>  #> ── Clinical Significance Results ── #>  #> Groupwise anchor-based approach (within groups) with a 8 point decrease in #> instrument scores indicating a clinical significant improvement. #>  #> Median Difference | [Lower | Upper] | CI-Level | n   | Category                            #> ------------------------------------------------------------------------------------------ #> -9.76             | -10.91 | -8.60  | 0.95     | 555 | Large clinically significant effect summary(cs_results_groupwise) #>  #> ── Clinical Significance Results ── #>  #> Groupwise anchor-based analysis of clinical significance (within groups) with a #> 8 point decrease in instrument scores (mom_di) indicating a clinical #> significant improvement. #>  #> There were 555 participants in the whole dataset of which 555 (100%) could be #> included in the analysis. #>  #>  #> ── Group Level Results  #>  #> Difference | [Lower | Upper] | CI-Level | n   | Category                            #> ----------------------------------------------------------------------------------- #> -9.76      | -10.91 | -8.60  | 0.95     | 555 | Large clinically significant effect plot(cs_results_groupwise)    # Group wise analysis, but split by experimentawl condition cs_results_groupwise_condition <- antidepressants |>   cs_anchor(     patient,     measurement,     mom_di,     pre = \"Before\",     group = condition,     mid_improvement = 8,     target = \"group\"   )  cs_results_groupwise_condition #>  #> ── Clinical Significance Results ── #>  #> Groupwise anchor-based approach (within groups) with a 8 point decrease in #> instrument scores indicating a clinical significant improvement. #>  #> Group            | Median Difference | [Lower | Upper] | CI-Level | n   | Category                                              #> ------------------------------------------------------------------------------------------------------------------------------- #> Wait List        | 1.80              | 0.17   | 3.44   | 0.95     | 152 | Statistically significant but not clinically relevant #> Inactive Placebo | -9.34             | -11.38 | -7.24  | 0.95     | 130 | Probably clinically significant effect                #> Active Placebo   | -17.01            | -18.97 | -15.04 | 0.95     | 121 | Large clinically significant effect                   #> Antidepressant   | -15.81            | -17.54 | -14.07 | 0.95     | 152 | Large clinically significant effect                   summary(cs_results_groupwise_condition) #>  #> ── Clinical Significance Results ── #>  #> Groupwise anchor-based analysis of clinical significance (within groups) with a #> 8 point decrease in instrument scores (mom_di) indicating a clinical #> significant improvement. #>  #> There were 555 participants in the whole dataset of which 555 (100%) could be #> included in the analysis. #>  #>  #> ── Group Level Results  #>  #> Group            | Difference | [Lower | Upper] | CI-Level | n   | Category                                              #> ------------------------------------------------------------------------------------------------------------------------ #> Wait List        | 1.80       | 0.17   | 3.44   | 0.95     | 152 | Statistically significant but not clinically relevant #> Inactive Placebo | -9.34      | -11.38 | -7.24  | 0.95     | 130 | Probably clinically significant effect                #> Active Placebo   | -17.01     | -18.97 | -15.04 | 0.95     | 121 | Large clinically significant effect                   #> Antidepressant   | -15.81     | -17.54 | -14.07 | 0.95     | 152 | Large clinically significant effect                   plot(cs_results_groupwise_condition)    # Compare all groups to a predefined reference group at a predefined measurement cs_results_groupwise_between <- antidepressants |>   cs_anchor(     patient,     measurement,     mom_di,     post = \"After\",     group = condition,     mid_improvement = 8,     target = \"group\",     effect = \"between\"   )  cs_results_groupwise_between #>  #> ── Clinical Significance Results ── #>  #> Groupwise anchor-based approach (between groups) with a 8 point decrease in #> instrument scores indicating a clinical significant improvement. #>  #> Group 1   | Group 2          | Median Difference | [Lower | Upper] | CI-Level | n (1) | n (2) | Category                            #> ----------------------------------------------------------------------------------------------------------------------------------- #> Wait List | Inactive Placebo | -11.69            | -13.39 | -10.07 | 0.95     | 152   | 130   | Large clinically significant effect #> Wait List | Active Placebo   | -17.66            | -19.47 | -15.94 | 0.95     | 152   | 121   | Large clinically significant effect #> Wait List | Antidepressant   | -18.44            | -20.22 | -16.71 | 0.95     | 152   | 152   | Large clinically significant effect summary(cs_results_groupwise_between) #>  #> ── Clinical Significance Results ── #>  #> Groupwise anchor-based analysis of clinical significance (between groups) with #> a 8 point decrease in instrument scores (mom_di) indicating a clinical #> significant improvement. #>  #>  #> ── Group Level Results  #>  #> Group 1   | Group 2          | Median Difference | [Lower | Upper] | CI-Level | n (1) | n (2) | Category                            #> ----------------------------------------------------------------------------------------------------------------------------------- #> Wait List | Inactive Placebo | -11.69            | -13.39 | -10.07 | 0.95     | 152   | 130   | Large clinically significant effect #> Wait List | Active Placebo   | -17.66            | -19.47 | -15.94 | 0.95     | 152   | 121   | Large clinically significant effect #> Wait List | Antidepressant   | -18.44            | -20.22 | -16.71 | 0.95     | 152   | 152   | Large clinically significant effect plot(cs_results_groupwise_between)    # Compare all groups to a predefined reference group with frequentist appraoch cs_results_groupwise_between_freq <- antidepressants |>   cs_anchor(     patient,     measurement,     mom_di,     post = \"After\",     group = condition,     mid_improvement = 8,     target = \"group\",     effect = \"between\",     bayesian = FALSE   )  cs_results_groupwise_between_freq #>  #> ── Clinical Significance Results ── #>  #> Groupwise anchor-based approach (between groups) with a 8 point decrease in #> instrument scores indicating a clinical significant improvement. #>  #> Group 1   | Group 2          | Mean Difference | [Lower | Upper] | CI-Level | n (1) | n (2) | Category                            #> --------------------------------------------------------------------------------------------------------------------------------- #> Wait List | Inactive Placebo | -11.81          | -13.44 | -10.18 | 0.95     | 152   | 130   | Large clinically significant effect #> Wait List | Active Placebo   | -17.79          | -19.54 | -16.05 | 0.95     | 152   | 121   | Large clinically significant effect #> Wait List | Antidepressant   | -18.52          | -20.25 | -16.79 | 0.95     | 152   | 152   | Large clinically significant effect summary(cs_results_groupwise_between_freq) #>  #> ── Clinical Significance Results ── #>  #> Groupwise anchor-based analysis of clinical significance (between groups) with #> a 8 point decrease in instrument scores (mom_di) indicating a clinical #> significant improvement. #>  #>  #> ── Group Level Results  #>  #> Group 1   | Group 2          | Mean Difference | [Lower | Upper] | CI-Level | n (1) | n (2) | Category                            #> --------------------------------------------------------------------------------------------------------------------------------- #> Wait List | Inactive Placebo | -11.81          | -13.44 | -10.18 | 0.95     | 152   | 130   | Large clinically significant effect #> Wait List | Active Placebo   | -17.79          | -19.54 | -16.05 | 0.95     | 152   | 121   | Large clinically significant effect #> Wait List | Antidepressant   | -18.52          | -20.25 | -16.79 | 0.95     | 152   | 152   | Large clinically significant effect plot(cs_results_groupwise_between_freq)"},{"path":"/reference/cs_combined.html","id":null,"dir":"Reference","previous_headings":"","what":"Combined Analysis of Clinical Significance — cs_combined","title":"Combined Analysis of Clinical Significance — cs_combined","text":"cs_combined() can used determine clinical significance intervention studies employing combination distribution-based statistical approach. , assumed functional (non-clinical population) patient (clinical population) scores form two distinct distributions continuum. cs_combined() calculates cutoff point two populations well reliable change index (RCI) based provided instrument reliability estimate counts, many patients showed reliable change (likely due measurement error) switched clinical functional population intervention. Several methods calculating cutoff RCI available.","code":""},{"path":"/reference/cs_combined.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Combined Analysis of Clinical Significance — cs_combined","text":"","code":"cs_combined(   data,   id,   time,   outcome,   group = NULL,   pre = NULL,   post = NULL,   reliability = NULL,   reliability_post = NULL,   m_functional = NULL,   sd_functional = NULL,   better_is = c(\"lower\", \"higher\"),   rci_method = c(\"JT\", \"GLN\", \"HLL\", \"EN\", \"NK\", \"HA\", \"HLM\"),   cutoff_type = c(\"a\", \"b\", \"c\"),   significance_level = 0.05 )"},{"path":"/reference/cs_combined.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Combined Analysis of Clinical Significance — cs_combined","text":"data tidy data frame id Participant ID time Time variable outcome Outcome variable group Grouping variable (optional) pre Pre measurement (needed time variable contains two measurements) post Post measurement (needed time variable contains two measurements) reliability instrument's reliability estimate. selected NK method, specified reliability instrument's pre measurement reliability. needed HLM method. reliability_post instrument's reliability post measurement (needed NK method) m_functional Numeric, mean functional population. sd_functional Numeric, standard deviation functional population better_is direction means better outcome used instrument? Available \"lower\" (lower outcome scores desirable, default) \"higher\" (higher outcome scores desirable) rci_method Clinical significance method. Available \"JT\" (Jacobson & Truax, 1991, default) \"GLN\" (Gulliksen, Lord, Novick; Hsu, 1989, Hsu, 1995) \"HLL\" (Hsu, Linn & Nord; Hsu, 1989) \"EN\" (Edwards & Nunnally; Speer, 1992) \"NK\" (Nunnally & Kotsch, 1983), requires reliability estimate post measurement. supplied, reliability reliability_post assumed equal \"HA\" (Hageman & Arrindell, 1999) \"HLM\" (Hierarchical Linear Modeling; Raudenbush & Bryk, 2002), requires least three measurements per patient cutoff_type Cutoff type. Available \"\", \"b\", \"c\". Defaults \"\" \"c\" usually recommended. \"b\" \"c\", summary data functional population must given arguments m_functional sd_functional. significance_level Significance level alpha, defaults 0.05. choose \"HA\" method, value corresponds maximum risk misclassification","code":""},{"path":"/reference/cs_combined.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Combined Analysis of Clinical Significance — cs_combined","text":"S3 object class cs_analysis cs_combined","code":""},{"path":"/reference/cs_combined.html","id":"categories","dir":"Reference","previous_headings":"","what":"Categories","title":"Combined Analysis of Clinical Significance — cs_combined","text":"individual's change can categorized following groups: Recovered, .e., individual showed reliable change beneficial direction changed clinical functional population Improved, .e., individual showed reliable change beneficial direction change populations Unchanged, .e., individual showed reliable change Deteriorated, .e., individual showed reliable change disadvantageous direction change populations Harmed, .e., individual showed reliable change disadvantageous direction switched functional clinincal population","code":""},{"path":"/reference/cs_combined.html","id":"computational-details","dir":"Reference","previous_headings":"","what":"Computational details","title":"Combined Analysis of Clinical Significance — cs_combined","text":"three available cutoff types, namely , b, c can used \"draw line\" separate functional clinical population continuum. cutoff defined mean clinical population minus two times standard deviation (SD) clinical population. b defined mean functional population plus also two times SD clinical population. true \"negative\" outcomes, lower instrument score desirable. \"positive\" outcomes, higher scores beneficial, mean clinical population plus 2 \\(\\cdot\\) SD clinical population b mean functional population minus 2 \\(\\cdot\\) SD clinical population. summary statistics clinical population estimated provided data pre measurement. c defined midpoint populations based respective mean SD. order calculate b c, descriptive statistics functional population must provided. provided data, region change calculated individual change may likely due inherent measurement used instrument. concept also known minimally detectable change (MDC).","code":""},{"path":"/reference/cs_combined.html","id":"data-preparation","dir":"Reference","previous_headings":"","what":"Data preparation","title":"Combined Analysis of Clinical Significance — cs_combined","text":"data set must tidy, corresponds long data frame general. must contain patient identifier must unique per patient. Also, column containing different measurements outcome must supplied. participant-measurement combination must unique, instance, data must contain two \"\" measurements patient. Additionally, measurement column contains two values, first value based alphabetical, numerical factor ordering used pre measurement. instance, column contains measurements identifiers \"pre\" \"post\" strings, \"post\" sorted \"pre\" thus used \"pre\" measurement. function throw warning generally may want explicitly define \"pre\" \"post\" measurement arguments pre post. case two measurement identifiers, define pre post manually since function know pre post intervention measurements . data grouped, can specify group referencing grouping variable (see examples ). analysis run every group compare group differences.","code":""},{"path":[]},{"path":"/reference/cs_combined.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Combined Analysis of Clinical Significance — cs_combined","text":"","code":"cs_results <- claus_2020 |>   cs_combined(     id,     time,     bdi,     pre = 1,     post = 4,     reliability = 0.80   )  cs_results #>  #> ── Clinical Significance Results ── #>  #> Combined approach using the JT and statistical approach. #>  #> Category     |  n | Percent #> --------------------------- #> Recovered    | 10 |    0.25 #> Improved     |  8 |    0.20 #> Unchanged    | 22 |    0.55 #> Deteriorated |  0 |    0.00 #> Harmed       |  0 |    0.00 summary(cs_results) #>  #> ── Clinical Significance Results ── #>  #> Combined analysis of clinical significance using the JT and statistical #> approach method for calculating the RCI and population cutoffs. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> The outcome was bdi and the reliability was set to 0.8. #>  #> The cutoff type was a with a value of 19.16 based on the following sumamry #> statistics: #>  #>  #> ── Population Characteristics  #> M Clinical | SD Clinical | M Functional | SD Functional #> ------------------------------------------------------- #> 35.48      |        8.16 |          --- |           --- #>  #>  #> ── Individual Level Results  #> Category     |  n | Percent #> --------------------------- #> Recovered    | 10 |    0.25 #> Improved     |  8 |    0.20 #> Unchanged    | 22 |    0.55 #> Deteriorated |  0 |    0.00 #> Harmed       |  0 |    0.00 plot(cs_results)    # You can choose a different cutoff but must provide summary statistics for the # functional population cs_results_c <- claus_2020 |>   cs_combined(     id,     time,     bdi,     pre = 1,     post = 4,     reliability = 0.80,     m_functional = 8,     sd_functional = 8,     cutoff_type = \"c\"   )  cs_results_c #>  #> ── Clinical Significance Results ── #>  #> Combined approach using the JT and statistical approach. #>  #> Category     |  n | Percent #> --------------------------- #> Recovered    | 10 |    0.25 #> Improved     |  8 |    0.20 #> Unchanged    | 22 |    0.55 #> Deteriorated |  0 |    0.00 #> Harmed       |  0 |    0.00 summary(cs_results_c) #>  #> ── Clinical Significance Results ── #>  #> Combined analysis of clinical significance using the JT and statistical #> approach method for calculating the RCI and population cutoffs. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> The outcome was bdi and the reliability was set to 0.8. #>  #> The cutoff type was c with a value of 21.6 based on the following sumamry #> statistics: #>  #>  #> ── Population Characteristics  #> M Clinical | SD Clinical | M Functional | SD Functional #> ------------------------------------------------------- #> 35.48      |        8.16 |            8 |             8 #>  #>  #> ── Individual Level Results  #> Category     |  n | Percent #> --------------------------- #> Recovered    | 10 |    0.25 #> Improved     |  8 |    0.20 #> Unchanged    | 22 |    0.55 #> Deteriorated |  0 |    0.00 #> Harmed       |  0 |    0.00 plot(cs_results_c)    # You can group the analysis by providing a grouping variable in the data cs_results_grouped <- claus_2020 |>   cs_combined(     id,     time,     bdi,     pre = 1,     post = 4,     group = treatment,     reliability = 0.80,     m_functional = 8,     sd_functional = 8,     cutoff_type = \"c\"   )  cs_results_grouped #>  #> ── Clinical Significance Results ── #>  #> Combined approach using the JT and statistical approach. #>  #> Group |     Category |  n | Percent #> ----------------------------------- #> TAU   |    Recovered |  3 |    0.07 #> TAU   |     Improved |  2 |    0.05 #> TAU   |    Unchanged | 14 |    0.35 #> TAU   | Deteriorated |  0 |    0.00 #> TAU   |       Harmed |  0 |    0.00 #> PA    |    Recovered |  7 |    0.17 #> PA    |     Improved |  6 |    0.15 #> PA    |    Unchanged |  8 |    0.20 #> PA    | Deteriorated |  0 |    0.00 #> PA    |       Harmed |  0 |    0.00 summary(cs_results_grouped) #>  #> ── Clinical Significance Results ── #>  #> Combined analysis of clinical significance using the JT and statistical #> approach method for calculating the RCI and population cutoffs. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> The outcome was bdi and the reliability was set to 0.8. #>  #> The cutoff type was c with a value of 21.6 based on the following sumamry #> statistics: #>  #>  #> ── Population Characteristics  #> M Clinical | SD Clinical | M Functional | SD Functional #> ------------------------------------------------------- #> 35.48      |        8.16 |            8 |             8 #>  #>  #> ── Individual Level Results  #> Group |     Category |  n | Percent #> ----------------------------------- #> TAU   |    Recovered |  3 |    0.07 #> TAU   |     Improved |  2 |    0.05 #> TAU   |    Unchanged | 14 |    0.35 #> TAU   | Deteriorated |  0 |    0.00 #> TAU   |       Harmed |  0 |    0.00 #> PA    |    Recovered |  7 |    0.17 #> PA    |     Improved |  6 |    0.15 #> PA    |    Unchanged |  8 |    0.20 #> PA    | Deteriorated |  0 |    0.00 #> PA    |       Harmed |  0 |    0.00 plot(cs_results_grouped)"},{"path":"/reference/cs_distribution.html","id":null,"dir":"Reference","previous_headings":"","what":"Distribution-Based Analysis of Clinical Significance — cs_distribution","title":"Distribution-Based Analysis of Clinical Significance — cs_distribution","text":"cs_distribution() can used determine clinical significance intervention studies employing distribution-based approach. , reliable change index estimated provided data known reliability estimate indicates, observed individual change likely greater measurement error inherent used instrument. case, reliable change defined clinically significant. Several methods calculating RCI can chosen.","code":""},{"path":"/reference/cs_distribution.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Distribution-Based Analysis of Clinical Significance — cs_distribution","text":"","code":"cs_distribution(   data,   id,   time,   outcome,   group = NULL,   pre = NULL,   post = NULL,   reliability = NULL,   reliability_post = NULL,   better_is = c(\"lower\", \"higher\"),   rci_method = c(\"JT\", \"GLN\", \"HLL\", \"EN\", \"NK\", \"HA\", \"HLM\"),   significance_level = 0.05 )"},{"path":"/reference/cs_distribution.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Distribution-Based Analysis of Clinical Significance — cs_distribution","text":"data tidy data frame id Participant ID time Time variable outcome Outcome variable group Grouping variable (optional) pre Pre measurement (needed time variable contains two measurements) post Post measurement (needed time variable contains two measurements) reliability instrument's reliability estimate. selected NK method, specified reliability instrument's pre measurement reliability. needed HLM method. reliability_post instrument's reliability post measurement (needed NK method) better_is direction means better outcome used instrument? Available \"lower\" (lower outcome scores desirable, default) \"higher\" (higher outcome scores desirable) rci_method Clinical significance method. Available \"JT\" (Jacobson & Truax, 1991, default) \"GLN\" (Gulliksen, Lord, Novick; Hsu, 1989, Hsu, 1995) \"HLL\" (Hsu, Linn & Nord; Hsu, 1989) \"EN\" (Edwards & Nunnally; Speer, 1992) \"NK\" (Nunnally & Kotsch, 1983), requires reliability estimate post measurement. supplied, reliability reliability_post assumed equal \"HA\" (Hageman & Arrindell, 1999) \"HLM\" (Hierarchical Linear Modeling; Raudenbush & Bryk, 2002), requires least three measurements per patient significance_level Significance level alpha, defaults 0.05. choose \"HA\" method, value corresponds maximum risk misclassification","code":""},{"path":"/reference/cs_distribution.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Distribution-Based Analysis of Clinical Significance — cs_distribution","text":"S3 object class cs_analysis cs_distribution","code":""},{"path":"/reference/cs_distribution.html","id":"computational-details","dir":"Reference","previous_headings":"","what":"Computational details","title":"Distribution-Based Analysis of Clinical Significance — cs_distribution","text":"provided data, region change calculated individual change may likely due inherent measurement used instrument. concept also known minimally detectable change (MDC).","code":""},{"path":"/reference/cs_distribution.html","id":"categories","dir":"Reference","previous_headings":"","what":"Categories","title":"Distribution-Based Analysis of Clinical Significance — cs_distribution","text":"individual's change may categorized one following three categories: Improved, change greater RCI beneficial direction Unchanged, change within region may attributable measurement error Deteriorated, change greater RCI, disadvantageous direction methods developed deal data containing two measurements per individual, .e., pre intervention post intervention measurement. Hierarchical Linear Modeling (rci_method = \"HLM\") method can incorporate data multiple measurements can thus used least three measurements per participant.","code":""},{"path":"/reference/cs_distribution.html","id":"data-preparation","dir":"Reference","previous_headings":"","what":"Data preparation","title":"Distribution-Based Analysis of Clinical Significance — cs_distribution","text":"data set must tidy, corresponds long data frame general. must contain patient identifier must unique per patient. Also, column containing different measurements outcome must supplied. participant-measurement combination must unique, instance, data must contain two \"\" measurements patient. Additionally, measurement column contains two values, first value based alphabetical, numerical factor ordering used pre measurement. instance, column contains measurements identifiers \"pre\" \"post\" strings, \"post\" sorted \"pre\" thus used \"pre\" measurement. function throw warning generally may want explicitly define \"pre\" \"post\" measurement arguments pre post. case two measurement identifiers, define pre post manually since function know pre post intervention measurements . data grouped, can specify group referencing grouping variable (see examples ). analysis run every group compare group differences.","code":""},{"path":"/reference/cs_distribution.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Distribution-Based Analysis of Clinical Significance — cs_distribution","text":"Jacobson, N. S., & Truax, P. (1991). Clinical significance: statistical approach defining meaningful change psychotherapy research. Journal Consulting Clinical Psychology, 59(1), 12–19. https://doi.org/10.1037//0022-006X.59.1.12 Hsu, L. M. (1989). Reliable changes psychotherapy: Taking account regression toward mean. Behavioral Assessment, 11(4), 459–467. Hsu, L. M. (1995). Regression toward mean associated measurement error identification improvement deterioration psychotherapy. Journal Consulting Clinical Psychology, 63(1), 141–144. https://doi.org/10.1037//0022-006x.63.1.141 Speer, D. C. (1992). Clinically significant change: Jacobson Truax (1991) revisited. Journal Consulting Clinical Psychology, 60(3), 402–408. https://doi.org/10.1037/0022-006X.60.3.402 Nunnally, J. C., & Kotsch, W. E. (1983). Studies individual subjects: Logic methods analysis. British Journal Clinical Psychology, 22(2), 83–93. https://doi.org/10.1111/j.2044-8260.1983.tb00582.x Hageman, W. J., & Arrindell, W. . (1999). Establishing clinically significant change: increment precision distinction individual group level analysis. Behaviour Research Therapy, 37(12), 1169–1193. https://doi.org/10.1016/S0005-7967(99)00032-7 Raudenbush, S. W., & Bryk, . S. (2002). Hierarchical Linear Models - Applications Data Analysis Methods (2nd ed.). Sage Publications.","code":""},{"path":[]},{"path":"/reference/cs_distribution.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Distribution-Based Analysis of Clinical Significance — cs_distribution","text":"","code":"antidepressants |>   cs_distribution(patient, measurement, mom_di, reliability = 0.80) #> ℹ Your \"Before\" was set as pre measurement and and your \"After\" as post. #> • If that is not correct, please specify the pre measurement with the argument #>   \"pre\". #>  #> ── Clinical Significance Results ── #>  #> Distribution-based approach using the JT method. #>  #> Category     |   n | Percent #> ---------------------------- #> Improved     | 274 |    0.49 #> Unchanged    | 237 |    0.43 #> Deteriorated |  44 |    0.08   # Turn off the warning by providing the pre measurement time cs_results <- antidepressants |>   cs_distribution(     patient,     measurement,     mom_di,     pre = \"Before\",     reliability = 0.80   )  summary(cs_results) #>  #> ── Clinical Significance Results ── #>  #> Distribution-based analysis of clinical significance using the JT method for #> calculating the RCI. #>  #> There were 555 participants in the whole dataset of which 555 (100%) could be #> included in the analysis. #>  #> The outcome was mom_di and the reliability was set to 0.8. #>  #>  #> ── Individual Level Results  #> Category     |   n | Percent #> ---------------------------- #> Improved     | 274 |    0.49 #> Unchanged    | 237 |    0.43 #> Deteriorated |  44 |    0.08 plot(cs_results)    # If you use data with more than two measurements, you always have to define a # pre and post measurement cs_results <- claus_2020 |>   cs_distribution(     id,     time,     hamd,     pre = 1,     post = 4,     reliability = 0.80   )  cs_results #>  #> ── Clinical Significance Results ── #>  #> Distribution-based approach using the JT method. #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 29 |    0.72 #> Unchanged    | 10 |    0.25 #> Deteriorated |  1 |    0.03 summary(cs_results) #>  #> ── Clinical Significance Results ── #>  #> Distribution-based analysis of clinical significance using the JT method for #> calculating the RCI. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> The outcome was hamd and the reliability was set to 0.8. #>  #>  #> ── Individual Level Results  #> Category     |  n | Percent #> --------------------------- #> Improved     | 29 |    0.72 #> Unchanged    | 10 |    0.25 #> Deteriorated |  1 |    0.03 plot(cs_results)    # Set the rci_method argument to change the RCI method cs_results_ha <- claus_2020 |>   cs_distribution(     id,     time,     hamd,     pre = 1,     post = 4,     reliability = 0.80,     rci_method = \"HA\"   )  cs_results_ha #>  #> ── Clinical Significance Results ── #>  #> Distribution-based approach using the HA method. #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 32 |    0.80 #> Unchanged    |  7 |    0.17 #> Deteriorated |  1 |    0.03 summary(cs_results_ha) #>  #> ── Clinical Significance Results ── #>  #> Distribution-based analysis of clinical significance using the HA method for #> calculating the RCI. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> The outcome was hamd and the reliability was set to 0.8. #>  #>  #> ── Individual Level Results  #> Category     |  n | Percent #> --------------------------- #> Improved     | 32 |    0.80 #> Unchanged    |  7 |    0.17 #> Deteriorated |  1 |    0.03 plot(cs_results_ha)    # Group the analysis by providing a grouping variable cs_results_grouped <- claus_2020 |>   cs_distribution(     id,     time,     hamd,     pre = 1,     post = 4,     group = treatment,     reliability = 0.80   )  cs_results_grouped #>  #> ── Clinical Significance Results ── #>  #> Distribution-based approach using the JT method. #>  #> Group |     Category |  n | Percent #> ----------------------------------- #> TAU   |     Improved |  9 |    0.23 #> TAU   |    Unchanged |  9 |    0.23 #> TAU   | Deteriorated |  1 |    0.03 #> PA    |     Improved | 20 |    0.50 #> PA    |    Unchanged |  1 |    0.03 #> PA    | Deteriorated |  0 |    0.00 summary(cs_results_grouped) #>  #> ── Clinical Significance Results ── #>  #> Distribution-based analysis of clinical significance using the JT method for #> calculating the RCI. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> The outcome was hamd and the reliability was set to 0.8. #>  #>  #> ── Individual Level Results  #> Group |     Category |  n | Percent #> ----------------------------------- #> TAU   |     Improved |  9 |    0.23 #> TAU   |    Unchanged |  9 |    0.23 #> TAU   | Deteriorated |  1 |    0.03 #> PA    |     Improved | 20 |    0.50 #> PA    |    Unchanged |  1 |    0.03 #> PA    | Deteriorated |  0 |    0.00 plot(cs_results_grouped)    # Use more than two measurements cs_results_hlm <- claus_2020 |>   cs_distribution(     id,     time,     hamd,     rci_method = \"HLM\"   )  cs_results_hlm #>  #> ── Clinical Significance Results ── #>  #> Distribution-based approach using the HLM method. #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 11 |    0.28 #> Unchanged    | 20 |    0.50 #> Deteriorated |  9 |    0.23 summary(cs_results_hlm) #>  #> ── Clinical Significance Results ── #>  #> Distribution-based analysis of clinical significance using the HLM method for #> calculating the RCI. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> The outcome was hamd. #>  #>  #> ── Individual Level Results  #> Category     |  n | Percent #> --------------------------- #> Improved     | 11 |    0.28 #> Unchanged    | 20 |    0.50 #> Deteriorated |  9 |    0.23 plot(cs_results_hlm)"},{"path":"/reference/cs_get_cutoff.html","id":null,"dir":"Reference","previous_headings":"","what":"Get Used Cutoff And Type From A cs_analysis Object — cs_get_cutoff","title":"Get Used Cutoff And Type From A cs_analysis Object — cs_get_cutoff","text":"Get Used Cutoff Type cs_analysis Object","code":""},{"path":"/reference/cs_get_cutoff.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get Used Cutoff And Type From A cs_analysis Object — cs_get_cutoff","text":"","code":"cs_get_cutoff(x, with_descriptives = FALSE)"},{"path":"/reference/cs_get_cutoff.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get Used Cutoff And Type From A cs_analysis Object — cs_get_cutoff","text":"x cs_analysis object with_descriptives Logical indicating whether want retrieve cutoff type value summary statistics based . default FALSE.","code":""},{"path":"/reference/cs_get_cutoff.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get Used Cutoff And Type From A cs_analysis Object — cs_get_cutoff","text":"tibble cutoff information","code":""},{"path":"/reference/cs_get_cutoff.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get Used Cutoff And Type From A cs_analysis Object — cs_get_cutoff","text":"","code":"cs_results <- claus_2020 |>   cs_statistical(     id,     time,     bdi,     pre = 1,     post = 4,     m_functional = 8,     sd_functional = 8,     cutoff_type = \"c\"   )  cs_get_cutoff(cs_results) #> # A tibble: 1 × 2 #>   type  value #>   <chr> <dbl> #> 1 c      21.6 cs_get_cutoff(cs_results, with_descriptives = TRUE) #> # A tibble: 1 × 6 #>   m_clinical sd_clinical m_functional sd_functional type  value #>        <dbl>       <dbl>        <dbl>         <dbl> <chr> <dbl> #> 1       35.5        8.16            8             8 c      21.6"},{"path":"/reference/cs_get_cutoff_descriptives.html","id":null,"dir":"Reference","previous_headings":"","what":"Get Descriptives Used In The Cutoff Calculation — cs_get_cutoff_descriptives","title":"Get Descriptives Used In The Cutoff Calculation — cs_get_cutoff_descriptives","text":"Get Descriptives Used Cutoff Calculation","code":""},{"path":"/reference/cs_get_cutoff_descriptives.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get Descriptives Used In The Cutoff Calculation — cs_get_cutoff_descriptives","text":"","code":"cs_get_cutoff_descriptives(x)"},{"path":"/reference/cs_get_cutoff_descriptives.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get Descriptives Used In The Cutoff Calculation — cs_get_cutoff_descriptives","text":"x clinisig object","code":""},{"path":"/reference/cs_get_cutoff_descriptives.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get Descriptives Used In The Cutoff Calculation — cs_get_cutoff_descriptives","text":"tibble means standard deviations clinical functional population","code":""},{"path":"/reference/cs_get_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Get Data From A cs_analysis Object — cs_get_data","title":"Get Data From A cs_analysis Object — cs_get_data","text":"Get Data cs_analysis Object","code":""},{"path":"/reference/cs_get_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get Data From A cs_analysis Object — cs_get_data","text":"","code":"cs_get_data(x, dataset = \"data\")"},{"path":"/reference/cs_get_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get Data From A cs_analysis Object — cs_get_data","text":"x cs_analysis object. dataset dataset wish retrieve. Available options \"original\" (raw original dataset) \"wide\" (original dataset wide format) \"data\" (dataset used calculations). default \"data\"","code":""},{"path":"/reference/cs_get_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get Data From A cs_analysis Object — cs_get_data","text":"tibble","code":""},{"path":[]},{"path":"/reference/cs_get_data.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get Data From A cs_analysis Object — cs_get_data","text":"","code":"cs_results <- claus_2020 |>   cs_anchor(id, time, bdi, mid_improvement = 9, pre = 1, post = 4)  cs_get_data(cs_results) #> # A tibble: 40 × 4 #>       id   pre  post change #>    <dbl> <dbl> <dbl>  <dbl> #>  1     1    33    27     -6 #>  2     2    26    19     -7 #>  3     3    15     5    -10 #>  4     5    39    46      7 #>  5     6    22    28      6 #>  6     7    25    18     -7 #>  7     8    33    30     -3 #>  8     9    23     8    -15 #>  9    10    47    24    -23 #> 10    11    43    13    -30 #> # ℹ 30 more rows cs_get_data(cs_results, dataset = \"wide\") #> # A tibble: 43 × 3 #>       id   pre  post #>    <dbl> <dbl> <dbl> #>  1     1    33    27 #>  2     2    26    19 #>  3     3    15     5 #>  4     4    20    NA #>  5     5    39    46 #>  6     6    22    28 #>  7     7    25    18 #>  8     8    33    30 #>  9     9    23     8 #> 10    10    47    24 #> # ℹ 33 more rows cs_get_data(cs_results, dataset = \"original\") #> # A tibble: 172 × 9 #>       id   age sex    treatment  time   bdi shaps   who  hamd #>    <dbl> <dbl> <fct>  <fct>     <dbl> <dbl> <dbl> <dbl> <dbl> #>  1     1    54 Male   TAU           1    33     9     0    25 #>  2     1    54 Male   TAU           2    28     6     3    17 #>  3     1    54 Male   TAU           3    28     9     7    13 #>  4     1    54 Male   TAU           4    27     8     3    13 #>  5     2    52 Female PA            1    26    11     2    15 #>  6     2    52 Female PA            2    26    10     0    16 #>  7     2    52 Female PA            3    25    10     0     7 #>  8     2    52 Female PA            4    19     9     3    11 #>  9     3    54 Male   PA            1    15     2     0    28 #> 10     3    54 Male   PA            2    13     5     9    17 #> # ℹ 162 more rows"},{"path":"/reference/cs_get_n.html","id":null,"dir":"Reference","previous_headings":"","what":"Get Number Of Participants From A cs_analysis Object — cs_get_n","title":"Get Number Of Participants From A cs_analysis Object — cs_get_n","text":"cs_get_n() one can extract number participants used clinical significance analysis cs_analysisobject. may depend clinical significance approach missing values present dataset. individual analyses, missing values handled list-wise deletion. Consequently, individuals missing pre post intervention score omitted analyses.","code":""},{"path":"/reference/cs_get_n.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get Number Of Participants From A cs_analysis Object — cs_get_n","text":"","code":"cs_get_n(x, which = \"all\")"},{"path":"/reference/cs_get_n.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get Number Of Participants From A cs_analysis Object — cs_get_n","text":"x cs_analysis object n returned? Available options \"\", (default) returns number participants , original used data set \"original\", number participants original dataset \"used\", number participants used data set, conversion wide format omitting cases missing values","code":""},{"path":"/reference/cs_get_n.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get Number Of Participants From A cs_analysis Object — cs_get_n","text":"tibble number participants","code":""},{"path":[]},{"path":"/reference/cs_get_n.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get Number Of Participants From A cs_analysis Object — cs_get_n","text":"","code":"# n can be extracted for every approach cs_results_anchor <- claus_2020 |>   cs_anchor(     id,     time,     bdi,     pre = 1,     post = 4,     mid_improvement = 9   )  cs_results_distribution <- claus_2020 |>   cs_distribution(     id,     time,     bdi,     pre = 1,     post = 4,     reliability = 0.80   )  cs_results_statistical <- claus_2020 |>   cs_statistical(     id,     time,     bdi,     pre = 1,     post = 4,     m_functional = 8,     sd_functional = 8,     cutoff_type = \"c\"   )  cs_results_combined <- claus_2020 |>   cs_combined(     id,     time,     bdi,     pre = 1,     post = 4,     reliability = 0.80,     m_functional = 8,     sd_functional = 8,     cutoff_type = \"c\"   )  cs_results_percentage <- claus_2020 |>   cs_percentage(     id,     time,     bdi,     pre = 1,     post = 4,     pct_improvement = 0.3   )   cs_get_n(cs_results_anchor) #> # A tibble: 1 × 3 #>   n_original n_used percent_used #>        <int>  <int>        <dbl> #> 1         43     40        0.930 cs_get_n(cs_results_distribution) #> # A tibble: 1 × 3 #>   n_original n_used percent_used #>        <int>  <int>        <dbl> #> 1         43     40        0.930 cs_get_n(cs_results_statistical) #> # A tibble: 1 × 3 #>   n_original n_used percent_used #>        <int>  <int>        <dbl> #> 1         43     40        0.930 cs_get_n(cs_results_combined) #> # A tibble: 1 × 3 #>   n_original n_used percent_used #>        <int>  <int>        <dbl> #> 1         43     40        0.930 cs_get_n(cs_results_percentage) #> # A tibble: 1 × 3 #>   n_original n_used percent_used #>        <int>  <int>        <dbl> #> 1         43     40        0.930   # Get your desired n cs_get_n(cs_results_anchor, which = \"all\") #> # A tibble: 1 × 3 #>   n_original n_used percent_used #>        <int>  <int>        <dbl> #> 1         43     40        0.930 cs_get_n(cs_results_anchor, which = \"original\") #> # A tibble: 1 × 1 #>   n_original #>        <int> #> 1         43 cs_get_n(cs_results_anchor, which = \"used\") #> # A tibble: 1 × 1 #>   n_used #>    <int> #> 1     40"},{"path":"/reference/cs_get_reliability.html","id":null,"dir":"Reference","previous_headings":"","what":"Get Reliability Of A cs_analysis Object — cs_get_reliability","title":"Get Reliability Of A cs_analysis Object — cs_get_reliability","text":"Get Reliability cs_analysis Object","code":""},{"path":"/reference/cs_get_reliability.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get Reliability Of A cs_analysis Object — cs_get_reliability","text":"","code":"cs_get_reliability(x)"},{"path":"/reference/cs_get_reliability.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get Reliability Of A cs_analysis Object — cs_get_reliability","text":"x cs_analysis object","code":""},{"path":"/reference/cs_get_reliability.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get Reliability Of A cs_analysis Object — cs_get_reliability","text":"tibble showing reliability","code":""},{"path":[]},{"path":"/reference/cs_get_reliability.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get Reliability Of A cs_analysis Object — cs_get_reliability","text":"","code":"cs_results <- claus_2020 |>   cs_distribution(     id,     time,     bdi,     pre = 1,     post = 4,     reliability = 0.80   )   cs_get_reliability(cs_results) #> # A tibble: 1 × 1 #>   reliability #>         <dbl> #> 1         0.8"},{"path":"/reference/cs_percentage.html","id":null,"dir":"Reference","previous_headings":"","what":"Percentage-Change Analysis of Clinical Significance — cs_percentage","title":"Percentage-Change Analysis of Clinical Significance — cs_percentage","text":"cs_percentage() can used determine clinical significance intervention studies employing percentage-change approach. , individuals relative change compared pre intervention measurement change exceeds predefined change percent points, change deemed clinically significant.","code":""},{"path":"/reference/cs_percentage.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Percentage-Change Analysis of Clinical Significance — cs_percentage","text":"","code":"cs_percentage(   data,   id,   time,   outcome,   group = NULL,   pre = NULL,   post = NULL,   pct_improvement = NULL,   pct_deterioration = NULL,   better_is = c(\"lower\", \"higher\") )"},{"path":"/reference/cs_percentage.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Percentage-Change Analysis of Clinical Significance — cs_percentage","text":"data tidy data frame id Participant ID time Time variable outcome Outcome variable group Grouping variable (optional) pre Pre measurement (needed time variable contains two measurements) post Post measurement (needed time variable contains two measurements) pct_improvement Numeric, percent change indicates clinically significant improvement pct_deterioration Numeric, percent change indicates clinically significant deterioration (optional). set, pct_deterioration assumed equal pct_improvement better_is direction means better outcome used instrument? Available \"lower\" (lower outcome scores desirable, default) \"higher\" (higher outcome scores desirable)","code":""},{"path":"/reference/cs_percentage.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Percentage-Change Analysis of Clinical Significance — cs_percentage","text":"S3 object class cs_analysis cs_percentage","code":""},{"path":"/reference/cs_percentage.html","id":"computational-details","dir":"Reference","previous_headings":"","what":"Computational details","title":"Percentage-Change Analysis of Clinical Significance — cs_percentage","text":"participants change calculated divided pre intervention score estimate individual's percent change. percent change improvement well deterioration can provided separately pct_deterioration set, assumed pct_improvement.","code":""},{"path":"/reference/cs_percentage.html","id":"categories","dir":"Reference","previous_headings":"","what":"Categories","title":"Percentage-Change Analysis of Clinical Significance — cs_percentage","text":"individual's change may categorized one following three categories: Improved, change greater predefined percent change beneficial direction Unchanged, change within predefined percent change Deteriorated, change greater predefined percent change, disadvantageous direction","code":""},{"path":"/reference/cs_percentage.html","id":"data-preparation","dir":"Reference","previous_headings":"","what":"Data preparation","title":"Percentage-Change Analysis of Clinical Significance — cs_percentage","text":"data set must tidy, corresponds long data frame general. must contain patient identifier must unique per patient. Also, column containing different measurements outcome must supplied. participant-measurement combination must unique, instance, data must contain two \"\" measurements patient. Additionally, measurement column contains two values, first value based alphabetical, numerical factor ordering used pre measurement. instance, column contains measurements identifiers \"pre\" \"post\" strings, \"post\" sorted \"pre\" thus used \"pre\" measurement. function throw warning generally may want explicitly define \"pre\" \"post\" measurement arguments pre post. case two measurement identifiers, define pre post manually since function know pre post intervention measurements . data grouped, can specify group referencing grouping variable (see examples ). analysis run every group compare group differences.","code":""},{"path":[]},{"path":"/reference/cs_percentage.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Percentage-Change Analysis of Clinical Significance — cs_percentage","text":"","code":"cs_results <- claus_2020 |>   cs_percentage(     id,     time,     hamd,     pre = 1,     post = 4,     pct_improvement = 0.3   )  cs_results #>  #> ── Clinical Significance Results ── #>  #> Percentage-change approach with a 30% decrease in instrument scores indicating #> a clinical significant improvement. #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 25 |    0.62 #> Unchanged    | 15 |    0.38 #> Deteriorated |  0 |    0.00 summary(cs_results) #>  #> ── Clinical Significance Results ── #>  #> Percentage-change analysis of clinical significance with a 30% decrease in #> instrument scores indicating a clinical significant improvement. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #>  #> ── Individual Level Results  #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 25 |    0.62 #> Unchanged    | 15 |    0.38 #> Deteriorated |  0 |    0.00 plot(cs_results)    # You can set different thresholds for improvement and deterioration cs_results_2 <- claus_2020 |>   cs_percentage(     id,     time,     hamd,     pre = 1,     post = 4,     pct_improvement = 0.3,     pct_deterioration = 0.2   )  cs_results_2 #>  #> ── Clinical Significance Results ── #>  #> Percentage-change approach with a 30% decrease in instrument scores indicating #> a clinical significant improvement and a 20% increase in instrument scores #> indicating a clinical significant deterioration. #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 25 |    0.62 #> Unchanged    | 14 |    0.35 #> Deteriorated |  1 |    0.03 summary(cs_results_2) #>  #> ── Clinical Significance Results ── #>  #> Percentage-change analysis of clinical significance with a 30% decrease in #> instrument scores indicating a clinical significant improvement and a 20% #> increase in instrument scores indicating a clinical significant deterioration. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #>  #> ── Individual Level Results  #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 25 |    0.62 #> Unchanged    | 14 |    0.35 #> Deteriorated |  1 |    0.03 plot(cs_results_2)    # You can group the analysis by providing a group column from the data cs_results_grouped <- claus_2020 |>   cs_percentage(     id,     time,     hamd,     pre = 1,     post = 4,     pct_improvement = 0.3,     group = treatment   )  cs_results_grouped #>  #> ── Clinical Significance Results ── #>  #> Percentage-change approach with a 30% decrease in instrument scores indicating #> a clinical significant improvement. #>  #> Group |     Category |  n | Percent #> ----------------------------------- #> TAU   |     Improved |  6 |    0.15 #> TAU   |    Unchanged | 13 |    0.33 #> TAU   | Deteriorated |  0 |    0.00 #> PA    |     Improved | 19 |    0.47 #> PA    |    Unchanged |  2 |    0.05 #> PA    | Deteriorated |  0 |    0.00 summary(cs_results_grouped) #>  #> ── Clinical Significance Results ── #>  #> Percentage-change analysis of clinical significance with a 30% decrease in #> instrument scores indicating a clinical significant improvement. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #>  #> ── Individual Level Results  #>  #> Group |     Category |  n | Percent #> ----------------------------------- #> TAU   |     Improved |  6 |    0.15 #> TAU   |    Unchanged | 13 |    0.33 #> TAU   | Deteriorated |  0 |    0.00 #> PA    |     Improved | 19 |    0.47 #> PA    |    Unchanged |  2 |    0.05 #> PA    | Deteriorated |  0 |    0.00 plot(cs_results_grouped)    # The analyses can be performed for positive outcomes as well, i.e., outcomes # for which a higher value is beneficial cs_results_who <- claus_2020 |>   cs_percentage(     id,     time,     who,     pre = 1,     post = 4,     pct_improvement = 0.3,     better_is = \"higher\"   )  cs_results_who #>  #> ── Clinical Significance Results ── #>  #> Percentage-change approach with a 30% increase in instrument scores indicating #> a clinical significant improvement. #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 28 |    0.70 #> Unchanged    |  9 |    0.23 #> Deteriorated |  3 |    0.07 summary(cs_results_who) #>  #> ── Clinical Significance Results ── #>  #> Percentage-change analysis of clinical significance with a 30% increase in #> instrument scores indicating a clinical significant improvement. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #>  #> ── Individual Level Results  #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 28 |    0.70 #> Unchanged    |  9 |    0.23 #> Deteriorated |  3 |    0.07 plot(cs_results_who)  plot(cs_results_who, show = category)"},{"path":"/reference/cs_statistical.html","id":null,"dir":"Reference","previous_headings":"","what":"Statistical Analysis of Clinical Significance — cs_statistical","title":"Statistical Analysis of Clinical Significance — cs_statistical","text":"cs_statistical() can used determine clinical significance intervention studies employing statistical approach. , assumed functional (non-clinical population) patient (clinical population) scores form two distinct distributions continuum. cs_statistical() calculates cutoff point two populations counts, many patients changed clinical functional population intervention. Several methods calculating cutoff available.","code":""},{"path":"/reference/cs_statistical.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Statistical Analysis of Clinical Significance — cs_statistical","text":"","code":"cs_statistical(   data,   id,   time,   outcome,   group = NULL,   pre = NULL,   post = NULL,   m_functional = NULL,   sd_functional = NULL,   reliability = NULL,   better_is = c(\"lower\", \"higher\"),   cutoff_method = c(\"JT\", \"HA\"),   cutoff_type = c(\"a\", \"b\", \"c\"),   significance_level = 0.05 )"},{"path":"/reference/cs_statistical.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Statistical Analysis of Clinical Significance — cs_statistical","text":"data tidy data frame id Participant ID time Time variable outcome Outcome variable group Grouping variable (optional) pre Pre measurement (needed time variable contains two measurements) post Post measurement (needed time variable contains two measurements) m_functional Numeric, mean functional population. sd_functional Numeric, standard deviation functional population reliability instrument's reliability estimate. selected NK method, specified reliability instrument's pre measurement reliability. needed HLM method. better_is direction means better outcome used instrument? Available \"lower\" (lower outcome scores desirable, default) \"higher\" (higher outcome scores desirable) cutoff_method Cutoff method, Available \"JT\" (Jacobson & Truax, 1991, default) \"HA\" (Hageman & Arrindell, 1999) cutoff_type Cutoff type. Available \"\", \"b\", \"c\". Defaults \"\" \"c\" usually recommended. \"b\" \"c\", summary data functional population must given arguments m_functional sd_functional. significance_level Significance level alpha, defaults 0.05. choose \"HA\" method, value corresponds maximum risk misclassification","code":""},{"path":"/reference/cs_statistical.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Statistical Analysis of Clinical Significance — cs_statistical","text":"S3 object class cs_analysis cs_statistical","code":""},{"path":"/reference/cs_statistical.html","id":"computational-details","dir":"Reference","previous_headings":"","what":"Computational details","title":"Statistical Analysis of Clinical Significance — cs_statistical","text":"three available cutoff types, namely , b, c can used \"draw line\" separate functional clinical population continuum. cutoff defined mean clinical population minus two times standard deviation (SD) clinical population. b defined mean functional population plus also two times SD clinical population. true \"negative\" outcomes, lower instrument score desirable. \"positive\" outcomes, higher scores beneficial, mean clinical population plus 2 \\(\\cdot\\) SD clinical population b mean functional population minus 2 \\(\\cdot\\) SD clinical population. summary statistics clinical population estimated provided data pre measurement. c defined midpoint populations based respective mean SD. order calculate b c, descriptive statistics functional population must provided.","code":""},{"path":"/reference/cs_statistical.html","id":"categories","dir":"Reference","previous_headings":"","what":"Categories","title":"Statistical Analysis of Clinical Significance — cs_statistical","text":"Individual patients can categorized one following groups: Improved, .e., one changed clinical functional population Unchanged, .e., one can seen member population pre post intervention Deteriorated, .e., one changed functional clinical population intervention","code":""},{"path":"/reference/cs_statistical.html","id":"data-preparation","dir":"Reference","previous_headings":"","what":"Data preparation","title":"Statistical Analysis of Clinical Significance — cs_statistical","text":"data set must tidy, corresponds long data frame general. must contain patient identifier must unique per patient. Also, column containing different measurements outcome must supplied. participant-measurement combination must unique, instance, data must contain two \"\" measurements patient. Additionally, measurement column contains two values, first value based alphabetical, numerical factor ordering used pre measurement. instance, column contains measurements identifiers \"pre\" \"post\" strings, \"post\" sorted \"pre\" thus used \"pre\" measurement. function throw warning generally may want explicitly define \"pre\" \"post\" measurement arguments pre post. case two measurement identifiers, define pre post manually since function know pre post intervention measurements . data grouped, can specify group referencing grouping variable (see examples ). analysis run every group compare group differences.","code":""},{"path":"/reference/cs_statistical.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Statistical Analysis of Clinical Significance — cs_statistical","text":"Jacobson, N. S., & Truax, P. (1991). Clinical significance: statistical approach defining meaningful change psychotherapy research. Journal Consulting Clinical Psychology, 59(1), 12–19. https://doi.org/10.1037//0022-006X.59.1.12 Hageman, W. J., & Arrindell, W. . (1999). Establishing clinically significant change: increment precision distinction individual group level analysis. Behaviour Research Therapy, 37(12), 1169–1193. https://doi.org/10.1016/S0005-7967(99)00032-7","code":""},{"path":[]},{"path":"/reference/cs_statistical.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Statistical Analysis of Clinical Significance — cs_statistical","text":"","code":"# By default, cutoff type \"a\" is used cs_results <- claus_2020 |>   cs_statistical(id, time, hamd, pre = 1, post = 4)  cs_results #>  #> ── Clinical Significance Results ── #>  #> Statistical approach using the JT method. #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 26 |    0.65 #> Unchanged    | 13 |    0.33 #> Deteriorated |  1 |    0.03 summary(cs_results) #>  #> ── Clinical Significance Results ── #>  #> Statistical approach of clinical significance using the JT method for #> calculating the population cutoff. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> The cutoff type was a with a value of 18.17 based on the following sumamry #> statistics: #>  #>  #> ── Population Characteristics  #> M Clinical | SD Clinical | M Functional | SD Functional #> ------------------------------------------------------- #> 24.85      |        3.34 |          --- |           --- #>  #>  #> ── Individual Level Results  #> Category     |  n | Percent #> --------------------------- #> Improved     | 26 |    0.65 #> Unchanged    | 13 |    0.33 #> Deteriorated |  1 |    0.03 plot(cs_results)    # You can choose a different cutoff type but need to provide additional # population summary statistics for the functional population cs_results_c <- claus_2020 |>   cs_statistical(     id,     time,     hamd,     pre = 1,     post = 4,     m_functional = 8,     sd_functional = 8,     cutoff_type = \"c\"   )  cs_results_c #>  #> ── Clinical Significance Results ── #>  #> Statistical approach using the JT method. #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 26 |    0.65 #> Unchanged    | 13 |    0.33 #> Deteriorated |  1 |    0.03 summary(cs_results_c) #>  #> ── Clinical Significance Results ── #>  #> Statistical approach of clinical significance using the JT method for #> calculating the population cutoff. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> The cutoff type was c with a value of 19.89 based on the following sumamry #> statistics: #>  #>  #> ── Population Characteristics  #> M Clinical | SD Clinical | M Functional | SD Functional #> ------------------------------------------------------- #> 24.85      |        3.34 |            8 |             8 #>  #>  #> ── Individual Level Results  #> Category     |  n | Percent #> --------------------------- #> Improved     | 26 |    0.65 #> Unchanged    | 13 |    0.33 #> Deteriorated |  1 |    0.03 plot(cs_results_c)    # You can use a different method to calculate the cutoff cs_results_ha <- claus_2020 |>   cs_statistical(     id,     time,     hamd,     pre = 1,     post = 4,     m_functional = 8,     sd_functional = 8,     reliability = 0.80,     cutoff_type = \"c\",     cutoff_method = \"HA\"   )  cs_results_ha #>  #> ── Clinical Significance Results ── #>  #> Statistical approach using the HA method. #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 23 |    0.57 #> Unchanged    | 17 |    0.42 #> Deteriorated |  0 |    0.00 summary(cs_results_ha) #>  #> ── Clinical Significance Results ── #>  #> Statistical approach of clinical significance using the HA method for #> calculating the population cutoff. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> The cutoff type was c_true with a value of 20.21 based on the following sumamry #> statistics: #>  #>  #> ── Population Characteristics  #> M Clinical | SD Clinical | M Functional | SD Functional #> ------------------------------------------------------- #> 24.85      |        3.34 |            8 |             8 #>  #>  #> ── Individual Level Results  #> Category     |  n | Percent #> --------------------------- #> Improved     | 23 |    0.57 #> Unchanged    | 17 |    0.42 #> Deteriorated |  0 |    0.00 plot(cs_results_ha)    # And you can group the analysis by providing a grouping variable from the data cs_results_grouped <- claus_2020 |>   cs_statistical(     id,     time,     hamd,     pre = 1,     post = 4,     m_functional = 8,     sd_functional = 8,     cutoff_type = \"c\",     group = treatment   )  cs_results_grouped #>  #> ── Clinical Significance Results ── #>  #> Statistical approach using the JT method. #>  #> Group |     Category |  n | Percent #> ----------------------------------- #> TAU   |     Improved |  7 |    0.17 #> TAU   |    Unchanged | 11 |    0.28 #> TAU   | Deteriorated |  1 |    0.03 #> PA    |     Improved | 19 |    0.47 #> PA    |    Unchanged |  2 |    0.05 #> PA    | Deteriorated |  0 |    0.00 summary(cs_results_grouped) #>  #> ── Clinical Significance Results ── #>  #> Statistical approach of clinical significance using the JT method for #> calculating the population cutoff. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> The cutoff type was c with a value of 19.89 based on the following sumamry #> statistics: #>  #>  #> ── Population Characteristics  #> M Clinical | SD Clinical | M Functional | SD Functional #> ------------------------------------------------------- #> 24.85      |        3.34 |            8 |             8 #>  #>  #> ── Individual Level Results  #> Group |     Category |  n | Percent #> ----------------------------------- #> TAU   |     Improved |  7 |    0.17 #> TAU   |    Unchanged | 11 |    0.28 #> TAU   | Deteriorated |  1 |    0.03 #> PA    |     Improved | 19 |    0.47 #> PA    |    Unchanged |  2 |    0.05 #> PA    | Deteriorated |  0 |    0.00 plot(cs_results_grouped)"},{"path":"/reference/jacobson_1989.html","id":null,"dir":"Reference","previous_headings":"","what":"Marital Therapy Data — jacobson_1989","title":"Marital Therapy Data — jacobson_1989","text":"dataset containing data Jacobson et al. (1989). purpose study examine two forms behavioral marital therapy,","code":""},{"path":"/reference/jacobson_1989.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Marital Therapy Data — jacobson_1989","text":"","code":"jacobson_1989"},{"path":"/reference/jacobson_1989.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Marital Therapy Data — jacobson_1989","text":"object class tbl_df 60 rows 4 columns. subject Subject ID time Measurement das Dyadic Adjustment Scale score (higher better) gds Global Distress Scale score (lower better)","code":""},{"path":"/reference/jacobson_1989.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Marital Therapy Data — jacobson_1989","text":"Jacobson, N. S., Schmaling, K. B., Holtzworth-Munroe, ., Katt, J. L., Wood, L. F., & Follette, V. M. (1989). Research-structured vs clinically flexible versions social learning-based marital therapy. Behaviour Research Therapy, 27(2), 173-180. https://doi.org/10.1016/0005-7967(89)90076-4 Jacobson, N. S., & Truax, P. (1991). Clinical significance: statistical approach defining meaningful change psychotherapy research. Journal Consulting Clinical Psychology, 59(1), 12-19. https://doi.org/10.1037//0022-006X.59.1.12","code":""},{"path":"/reference/plot.cs_anchor_group_between.html","id":null,"dir":"Reference","previous_headings":"","what":"Plot an Object of Class cs_anchor_group_between — plot.cs_anchor_group_between","title":"Plot an Object of Class cs_anchor_group_between — plot.cs_anchor_group_between","text":"function creates generic group level clinical significance plot plotting group change associated uncertainty interval around estimated change y-axis.","code":""},{"path":"/reference/plot.cs_anchor_group_between.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Plot an Object of Class cs_anchor_group_between — plot.cs_anchor_group_between","text":"","code":"# S3 method for cs_anchor_group_between plot(   x,   x_lab = \"Group\",   y_lab = \"Mean Intervention Effect\\n(with 95%-CI)\",   ... )"},{"path":"/reference/plot.cs_anchor_group_between.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Plot an Object of Class cs_anchor_group_between — plot.cs_anchor_group_between","text":"x object class cs_anchor_group_between x_lab String, x axis label, defaults \"Group\" y_lab String, y axis label, defaults \"Mean Intervention Effect (95%-CI)\" ... Additional arguments","code":""},{"path":"/reference/plot.cs_anchor_group_between.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Plot an Object of Class cs_anchor_group_between — plot.cs_anchor_group_between","text":"ggplot2 plot","code":""},{"path":"/reference/plot.cs_anchor_group_between.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Plot an Object of Class cs_anchor_group_between — plot.cs_anchor_group_between","text":"","code":"cs_results <- antidepressants |>   cs_anchor(     patient,     measurement,     mom_di,     mid_improvement = 8,     target = \"group\",     group = condition,     effect = \"between\",     post = \"After\"   )   # Plot the results \"as is\" plot(cs_results)    # Change the axis labels plot(cs_results, x_lab = \"Condition\", y_lab = \"Treatment Effect\")"},{"path":"/reference/plot.cs_anchor_group_within.html","id":null,"dir":"Reference","previous_headings":"","what":"Plot an Object of Class cs_anchor_group_within — plot.cs_anchor_group_within","title":"Plot an Object of Class cs_anchor_group_within — plot.cs_anchor_group_within","text":"function creates generic group level clinical significance plot plotting within group change associated uncertainty interval around estimated change y-axis.","code":""},{"path":"/reference/plot.cs_anchor_group_within.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Plot an Object of Class cs_anchor_group_within — plot.cs_anchor_group_within","text":"","code":"# S3 method for cs_anchor_group_within plot(   x,   x_lab = \"Group\",   y_lab = \"Mean Intervention Effect\\n(with 95%-CI)\",   ... )"},{"path":"/reference/plot.cs_anchor_group_within.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Plot an Object of Class cs_anchor_group_within — plot.cs_anchor_group_within","text":"x object class cs_anchor_group_within x_lab String, x axis label. Defaults \"Group\" y_lab String, y axis label, defaults \"Mean Intervention Effect (95%-CI)\" ... Additional arguments","code":""},{"path":"/reference/plot.cs_anchor_group_within.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Plot an Object of Class cs_anchor_group_within — plot.cs_anchor_group_within","text":"ggplot2 plot","code":""},{"path":"/reference/plot.cs_anchor_group_within.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Plot an Object of Class cs_anchor_group_within — plot.cs_anchor_group_within","text":"","code":"cs_results <- antidepressants |>   cs_anchor(     patient,     measurement,     mom_di,     mid_improvement = 8,     target = \"group\",     group = condition   ) #> ℹ Your \"Before\" was set as pre measurement and and your \"After\" as post. #> • If that is not correct, please specify the pre measurement with the argument #>   \"pre\".   # Plot the results \"as is\" plot(cs_results)    # Change the axis labels plot(cs_results, x_lab = \"Condition\", y_lab = \"Treatment Effect\")"},{"path":"/reference/plot.cs_anchor_individual_within.html","id":null,"dir":"Reference","previous_headings":"","what":"Plot an Object of Class cs_anchor_individual_within — plot.cs_anchor_individual_within","title":"Plot an Object of Class cs_anchor_individual_within — plot.cs_anchor_individual_within","text":"function creates generic clinical significance plot plotting patients' pre intervention value x-axis post intervention score y-axis.","code":""},{"path":"/reference/plot.cs_anchor_individual_within.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Plot an Object of Class cs_anchor_individual_within — plot.cs_anchor_individual_within","text":"","code":"# S3 method for cs_anchor_individual_within plot(   x,   x_lab = \"Pre\",   y_lab = \"Post\",   color_lab = \"Group\",   lower_limit,   upper_limit,   show,   point_alpha = 1,   mid_fill = \"grey10\",   mid_alpha = 0.1,   overplotting = 0.02,   ... )"},{"path":"/reference/plot.cs_anchor_individual_within.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Plot an Object of Class cs_anchor_individual_within — plot.cs_anchor_individual_within","text":"x object class cs_distribution x_lab String, x axis label. Default \"Pre\". y_lab String, x axis label. Default \"Post\". color_lab String, color label (colors displayed). Default \"Group\" lower_limit Numeric, lower plotting limit. Defaults 2% smaller minimum instrument score upper_limit Numeric, upper plotting limit. Defaults 2% larger maximum instrument score show Unquoted category name. several options color different features. Available improved (shows improved participants) unchanged (shows unchanged participants) deteriorated (shows deteriorated participants) point_alpha Numeric, transparency adjustment points. value 0 1 1 corresponds transparent 0 fully transparent. mid_fill String, color (name HEX code) percentage range fill mid_alpha Numeric, controls transparency percentage fill. can value 0 1, defaults 0.1 overplotting Numeric, control amount overplotting. Defaults 0.02 (.e., 2% range lower upper limit). ... Additional arguments","code":""},{"path":"/reference/plot.cs_anchor_individual_within.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Plot an Object of Class cs_anchor_individual_within — plot.cs_anchor_individual_within","text":"ggplot2 plot","code":""},{"path":"/reference/plot.cs_anchor_individual_within.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Plot an Object of Class cs_anchor_individual_within — plot.cs_anchor_individual_within","text":"","code":"cs_results <- antidepressants |>   cs_anchor(     patient,     measurement,     pre = \"Before\",     mom_di,     mid_improvement = 8   )   # Plot the results \"as is\" plot(cs_results)    # Change the axis labels plot(cs_results, x_lab = \"Before Intervention\", y_lab = \"After Intervention\")    # Show the individual categories plot(cs_results, show = category)    # Show a specific category plot(cs_results, show = improved)    # Show groups as specified in the data cs_results_grouped <- antidepressants |>   cs_anchor(     patient,     measurement,     pre = \"Before\",     mom_di,     mid_improvement = 8,     group = condition   )  plot(cs_results_grouped)    # To avoid overplotting, generic ggplot2 code can be used to facet the plot library(ggplot2) plot(cs_results_grouped) +   facet_wrap(~ group)    # Adjust the transparency of individual data points plot(cs_results, point_alpha = 0.3)    # Adjust the fill and transparency of the \"unchanged\" (PCC) region plot(cs_results, mid_fill = \"firebrick\", mid_alpha = 0.2)    # Control the overplotting plot(cs_results, overplotting = 0.1)    # Or adjust the axis limits by hand plot(cs_results, lower_limit = 0, upper_limit = 80)"},{"path":"/reference/plot.cs_combined.html","id":null,"dir":"Reference","previous_headings":"","what":"Plot an Object of Class cs_combined — plot.cs_combined","title":"Plot an Object of Class cs_combined — plot.cs_combined","text":"function creates generic clinical significance plot plotting patients' pre intervention value x-axis post intervention score y-axis.","code":""},{"path":"/reference/plot.cs_combined.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Plot an Object of Class cs_combined — plot.cs_combined","text":"","code":"# S3 method for cs_combined plot(   x,   x_lab = NULL,   y_lab = NULL,   color_lab = \"Group\",   lower_limit,   upper_limit,   show,   point_alpha = 1,   trajectory_alpha = 1,   rci_fill = \"grey10\",   rci_alpha = 0.1,   overplotting = 0.02,   ... )"},{"path":"/reference/plot.cs_combined.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Plot an Object of Class cs_combined — plot.cs_combined","text":"x object class cs_distribution x_lab String, x axis label. Default \"Pre\". y_lab String, x axis label. Default \"Post\". color_lab String, color label (colors displayed). Default \"Group\" lower_limit Numeric, lower plotting limit. Defaults 2% smaller minimum instrument score upper_limit Numeric, upper plotting limit. Defaults 2% larger maximum instrument score show Unquoted category name. several options color different features. Available category (shows categories ) recovered (shows recovered participants) improved (shows improved participants) unchanged (shows unchanged participants) deteriorated (shows deteriorated participants) harmed (shows harmed participants) point_alpha Numeric, transparency adjustment points. value 0 1 1 corresponds transparent 0 fully transparent. trajectory_alpha Numeric, transparency adjustment trajectories. value 0 1 1 corresponds transparent 0 fully transparent. rci_fill String, color (name HEX code) RCI fill rci_alpha Numeric, controls transparency RCI. can value 0 1, defaults 0.1 overplotting Numeric, control amount overplotting. Defaults 0.02 (.e., 2% range lower upper limit). ... Additional arguments","code":""},{"path":"/reference/plot.cs_combined.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Plot an Object of Class cs_combined — plot.cs_combined","text":"ggplot2 plot","code":""},{"path":"/reference/plot.cs_combined.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Plot an Object of Class cs_combined — plot.cs_combined","text":"","code":"cs_results <- antidepressants |>   cs_combined(     patient,     measurement,     pre = \"Before\",     mom_di,     reliability = 0.80,     m_functional = 15,     sd_functional = 8,     cutoff_type = \"c\"   )   # Plot the results \"as is\" plot(cs_results)    # Change the axis labels plot(cs_results, x_lab = \"Before Intervention\", y_lab = \"After Intervention\")    # Show the individual categories plot(cs_results, show = category)    # Show a specific plot(cs_results, show = recovered)    # Show groups as specified in the data cs_results_grouped <- antidepressants |>   cs_combined(     patient,     measurement,     pre = \"Before\",     mom_di,     reliability = 0.80,     m_functional = 15,     sd_functional = 8,     cutoff_type = \"c\",     group = condition   )  plot(cs_results_grouped)    # To avoid overplotting, generic ggplot2 code can be used to facet the plot library(ggplot2) plot(cs_results_grouped) +   facet_wrap(~ group)    # Adjust the transparency of individual data points plot(cs_results, point_alpha = 0.3)    # Adjust the fill and transparency of the \"unchanged\" (RCI) region plot(cs_results, rci_fill = \"firebrick\", rci_alpha = 0.2)    # Control the overplotting plot(cs_results, overplotting = 0.1)    # Or adjust the axis limits by hand plot(cs_results, lower_limit = 0, upper_limit = 80)"},{"path":"/reference/plot.cs_distribution.html","id":null,"dir":"Reference","previous_headings":"","what":"Plot an Object of Class cs_distribution — plot.cs_distribution","title":"Plot an Object of Class cs_distribution — plot.cs_distribution","text":"function creates generic clinical significance plot plotting patients' pre intervention value x-axis post intervention score y-axis.","code":""},{"path":"/reference/plot.cs_distribution.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Plot an Object of Class cs_distribution — plot.cs_distribution","text":"","code":"# S3 method for cs_distribution plot(   x,   x_lab = NULL,   y_lab = NULL,   color_lab = \"Group\",   lower_limit,   upper_limit,   show,   point_alpha = 1,   trajectory_alpha = 1,   rci_fill = \"grey10\",   rci_alpha = 0.1,   overplotting = 0.02,   ... )"},{"path":"/reference/plot.cs_distribution.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Plot an Object of Class cs_distribution — plot.cs_distribution","text":"x object class cs_distribution x_lab String, x axis label. Default \"Pre\". y_lab String, x axis label. Default \"Post\". color_lab String, color label (colors displayed). Default \"Group\" lower_limit Numeric, lower plotting limit. Defaults 2% smaller minimum instrument score upper_limit Numeric, upper plotting limit. Defaults 2% larger maximum instrument score show Unquoted category name. several options color different features. Available category (shows categories ) improved (shows improved participants) unchanged (shows unchanged participants) deteriorated (shows deteriorated participants) point_alpha Numeric, transparency adjustment points. value 0 1 1 corresponds transparent 0 fully transparent. trajectory_alpha Numeric, transparency adjustment trajectories. value 0 1 1 corresponds transparent 0 fully transparent. rci_fill String, color (name HEX code) RCI fill rci_alpha Numeric, controls transparency RCI. can value 0 1, defaults 0.1 overplotting Numeric, control amount overplotting. Defaults 0.02 (.e., 2% range lower upper limit). ... Additional arguments","code":""},{"path":"/reference/plot.cs_distribution.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Plot an Object of Class cs_distribution — plot.cs_distribution","text":"ggplot2 plot","code":""},{"path":"/reference/plot.cs_distribution.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Plot an Object of Class cs_distribution — plot.cs_distribution","text":"","code":"cs_results <- antidepressants |>   cs_distribution(     patient,     measurement,     pre = \"Before\",     mom_di,     reliability = 0.80   )   # Plot the results \"as is\" plot(cs_results)    # Change the axis labels plot(cs_results, x_lab = \"Before Intervention\", y_lab = \"After Intervention\")    # Show the individual categories plot(cs_results, show = category)    # Show a specific plot(cs_results, show = improved)    # Show groups as specified in the data cs_results_grouped <- antidepressants |>   cs_distribution(     patient,     measurement,     pre = \"Before\",     mom_di,     reliability = 0.80,     group = condition   )  plot(cs_results_grouped)    # To avoid overplotting, generic ggplot2 code can be used to facet the plot library(ggplot2) plot(cs_results_grouped) +   facet_wrap(~ group)    # Adjust the transparency of individual data points plot(cs_results, point_alpha = 0.3)    # Adjust the fill and transparency of the \"unchanged\" (RCI) region plot(cs_results, rci_fill = \"firebrick\", rci_alpha = 0.2)    # Control the overplotting plot(cs_results, overplotting = 0.1)    # Or adjust the axis limits by hand plot(cs_results, lower_limit = 0, upper_limit = 80)"},{"path":"/reference/plot.cs_percentage.html","id":null,"dir":"Reference","previous_headings":"","what":"Plot an Object of Class cs_percentage — plot.cs_percentage","title":"Plot an Object of Class cs_percentage — plot.cs_percentage","text":"function creates generic clinical significance plot plotting patients' pre intervention value x-axis post intervention score y-axis.","code":""},{"path":"/reference/plot.cs_percentage.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Plot an Object of Class cs_percentage — plot.cs_percentage","text":"","code":"# S3 method for cs_percentage plot(   x,   x_lab = \"Pre\",   y_lab = \"Post\",   color_lab = \"Group\",   lower_limit,   upper_limit,   show,   point_alpha = 1,   pct_fill = \"grey10\",   pct_alpha = 0.1,   overplotting = 0.02,   ... )"},{"path":"/reference/plot.cs_percentage.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Plot an Object of Class cs_percentage — plot.cs_percentage","text":"x object class cs_distribution x_lab String, x axis label. Default \"Pre\". y_lab String, x axis label. Default \"Post\". color_lab String, color label (colors displayed). Default \"Group\" lower_limit Numeric, lower plotting limit. Defaults 2% smaller minimum instrument score upper_limit Numeric, upper plotting limit. Defaults 2% larger maximum instrument score show Unquoted category name. several options color different features. Available improved (shows improved participants) unchanged (shows unchanged participants) deteriorated (shows deteriorated participants) point_alpha Numeric, transparency adjustment points. value 0 1 1 corresponds transparent 0 fully transparent. pct_fill String, color (name HEX code) percentage range fill pct_alpha Numeric, controls transparency percentage fill. can value 0 1, defaults 0.1 overplotting Numeric, control amount overplotting. Defaults 0.02 (.e., 2% range lower upper limit). ... Additional arguments","code":""},{"path":"/reference/plot.cs_percentage.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Plot an Object of Class cs_percentage — plot.cs_percentage","text":"ggplot2 plot","code":""},{"path":"/reference/plot.cs_percentage.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Plot an Object of Class cs_percentage — plot.cs_percentage","text":"","code":"cs_results <- antidepressants |>   cs_percentage(     patient,     measurement,     pre = \"Before\",     mom_di,     pct_improvement = 0.4   )   # Plot the results \"as is\" plot(cs_results)    # Change the axis labels plot(cs_results, x_lab = \"Before Intervention\", y_lab = \"After Intervention\")    # Show the individual categories plot(cs_results, show = category)    # Show a specific category plot(cs_results, show = improved)    # Show groups as specified in the data cs_results_grouped <- antidepressants |>   cs_percentage(     patient,     measurement,     pre = \"Before\",     mom_di,     pct_improvement = 0.4,     group = condition   )  plot(cs_results_grouped)    # To avoid overplotting, generic ggplot2 code can be used to facet the plot library(ggplot2) plot(cs_results_grouped) +   facet_wrap(~ group)    # Adjust the transparency of individual data points plot(cs_results, point_alpha = 0.3)    # Adjust the fill and transparency of the \"unchanged\" (PCC) region plot(cs_results, pct_fill = \"firebrick\", pct_alpha = 0.2)    # Control the overplotting plot(cs_results, overplotting = 0.1)    # Or adjust the axis limits by hand plot(cs_results, lower_limit = 0, upper_limit = 80)"},{"path":"/reference/plot.cs_statistical.html","id":null,"dir":"Reference","previous_headings":"","what":"Plot an Object of Class cs_statistical — plot.cs_statistical","title":"Plot an Object of Class cs_statistical — plot.cs_statistical","text":"function creates generic clinical significance plot plotting patients' pre intervention value x-axis post intervention score y-axis.","code":""},{"path":"/reference/plot.cs_statistical.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Plot an Object of Class cs_statistical — plot.cs_statistical","text":"","code":"# S3 method for cs_statistical plot(   x,   x_lab = \"Pre\",   y_lab = \"Post\",   color_lab = \"Group\",   include_cutoff = TRUE,   lower_limit,   upper_limit,   show,   point_alpha = 1,   overplotting = 0.02,   ... )"},{"path":"/reference/plot.cs_statistical.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Plot an Object of Class cs_statistical — plot.cs_statistical","text":"x object class cs_statistical x_lab String, x axis label. Default \"Pre\". y_lab String, x axis label. Default \"Post\". color_lab String, color label (colors displayed). Default \"Group\" include_cutoff Logical, whether include population cutoff. Default TRUE. lower_limit Numeric, lower plotting limit. Defaults 2% smaller minimum instrument score upper_limit Numeric, upper plotting limit. Defaults 2% larger maximum instrument score show Unquoted category name. several options color different features. Available category (shows categories ) clinical_pre (shows participants clinical scores pre intervention) functional_post (shows participants functional scores post intervention) unchanged (shows unchanged participants) point_alpha Numeric, transparency adjustment points. value 0 1 1 corresponds transparent 0 fully transparent. overplotting Numeric, control amount overplotting. Defaults 0.02 (.e., 2% range lower upper limit). ... Additional arguments","code":""},{"path":"/reference/plot.cs_statistical.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Plot an Object of Class cs_statistical — plot.cs_statistical","text":"ggplot2 plot","code":""},{"path":"/reference/plot.cs_statistical.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Plot an Object of Class cs_statistical — plot.cs_statistical","text":"","code":"cs_results <- antidepressants |>   cs_statistical(     patient,     measurement,     pre = \"Before\",     mom_di,     m_functional = 15,     sd_functional = 8,     cutoff_type = \"c\"   )   # Plot the results \"as is\" plot(cs_results)    # Change the axis labels plot(cs_results, x_lab = \"Before Intervention\", y_lab = \"After Intervention\")    # Show the individual categories plot(cs_results, show = category)    # Show groups as specified in the data cs_results_grouped <- antidepressants |>   cs_statistical(     patient,     measurement,     pre = \"Before\",     mom_di,     m_functional = 15,     sd_functional = 8,     cutoff_type = \"c\",     group = condition   )  plot(cs_results_grouped)    # To avoid overplotting, generic ggplot2 code can be used to facet the plot library(ggplot2) plot(cs_results_grouped) +   facet_wrap(~ group)    # Adjust the transparency of individual data points plot(cs_results, point_alpha = 0.3)    # Control the overplotting plot(cs_results, overplotting = 0.1)    # Or adjust the axis limits by hand plot(cs_results, lower_limit = 0, upper_limit = 80)"},{"path":"/reference/plotting_band.html","id":null,"dir":"Reference","previous_headings":"","what":"Generic to Calculate RCI Band Data for Plotting — generate_plotting_band","title":"Generic to Calculate RCI Band Data for Plotting — generate_plotting_band","text":"internal generic generate data RCI band clinical significance plots. called directly.","code":""},{"path":"/reference/plotting_band.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Generic to Calculate RCI Band Data for Plotting — generate_plotting_band","text":"","code":"generate_plotting_band(x, lower_limit, upper_limit, ...)  # S3 method for cs_jt generate_plotting_band(x, lower_limit = 0, upper_limit = 100, ...)  # S3 method for cs_gln generate_plotting_band(x, lower_limit = 0, upper_limit = 100, ...)  # S3 method for cs_hll generate_plotting_band(x, lower_limit = 0, upper_limit = 100, ...)  # S3 method for cs_en generate_plotting_band(x, lower_limit = 0, upper_limit = 100, ...)  # S3 method for cs_nk generate_plotting_band(x, lower_limit = 0, upper_limit = 100, ...)  # S3 method for cs_ha generate_plotting_band(x, lower_limit = 0, upper_limit = 100, ...)  # S3 method for cs_percentage generate_plotting_band(x, lower_limit = 0, upper_limit = 100, ...)  # S3 method for cs_anchor_individual_within generate_plotting_band(x, lower_limit = 0, upper_limit = 100, ...)"},{"path":"/reference/plotting_band.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Generic to Calculate RCI Band Data for Plotting — generate_plotting_band","text":"x object respective class lower_limit Lower plotting limit upper_limit Upper plotting limit ... Additional arguments","code":""},{"path":"/reference/plotting_band.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Generic to Calculate RCI Band Data for Plotting — generate_plotting_band","text":"tibble data ribbon indicating unchanged patients","code":""},{"path":"/reference/print.cs_anchor_group_between.html","id":null,"dir":"Reference","previous_headings":"","what":"Print Method for the Anchor-Based Approach for Groups (Between) — print.cs_anchor_group_between","title":"Print Method for the Anchor-Based Approach for Groups (Between) — print.cs_anchor_group_between","text":"Print Method Anchor-Based Approach Groups ()","code":""},{"path":"/reference/print.cs_anchor_group_between.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Print Method for the Anchor-Based Approach for Groups (Between) — print.cs_anchor_group_between","text":"","code":"# S3 method for cs_anchor_group_between print(x, ...)"},{"path":"/reference/print.cs_anchor_group_between.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Print Method for the Anchor-Based Approach for Groups (Between) — print.cs_anchor_group_between","text":"x object class cs_anchor_group_between ... Additional arguments","code":""},{"path":"/reference/print.cs_anchor_group_between.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Print Method for the Anchor-Based Approach for Groups (Between) — print.cs_anchor_group_between","text":"return value, called side effects","code":""},{"path":"/reference/print.cs_anchor_group_within.html","id":null,"dir":"Reference","previous_headings":"","what":"Print Method for the Anchor-Based Approach for Groups (Within) — print.cs_anchor_group_within","title":"Print Method for the Anchor-Based Approach for Groups (Within) — print.cs_anchor_group_within","text":"Print Method Anchor-Based Approach Groups (Within)","code":""},{"path":"/reference/print.cs_anchor_group_within.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Print Method for the Anchor-Based Approach for Groups (Within) — print.cs_anchor_group_within","text":"","code":"# S3 method for cs_anchor_group_within print(x, ...)"},{"path":"/reference/print.cs_anchor_group_within.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Print Method for the Anchor-Based Approach for Groups (Within) — print.cs_anchor_group_within","text":"x object class cs_anchor_group_within ... Additional arguments","code":""},{"path":"/reference/print.cs_anchor_group_within.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Print Method for the Anchor-Based Approach for Groups (Within) — print.cs_anchor_group_within","text":"return value, called side effects","code":""},{"path":"/reference/print.cs_anchor_group_within.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Print Method for the Anchor-Based Approach for Groups (Within) — print.cs_anchor_group_within","text":"","code":"cs_results <- claus_2020 |>   cs_distribution(id, time, hamd, pre = 1, post = 4, reliability = 0.8) cs_results #>  #> ── Clinical Significance Results ── #>  #> Distribution-based approach using the JT method. #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 29 |    0.72 #> Unchanged    | 10 |    0.25 #> Deteriorated |  1 |    0.03"},{"path":"/reference/print.cs_anchor_individual_within.html","id":null,"dir":"Reference","previous_headings":"","what":"Print Method for the Anchor-Based Approach for Individuals — print.cs_anchor_individual_within","title":"Print Method for the Anchor-Based Approach for Individuals — print.cs_anchor_individual_within","text":"Print Method Anchor-Based Approach Individuals","code":""},{"path":"/reference/print.cs_anchor_individual_within.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Print Method for the Anchor-Based Approach for Individuals — print.cs_anchor_individual_within","text":"","code":"# S3 method for cs_anchor_individual_within print(x, ...)"},{"path":"/reference/print.cs_anchor_individual_within.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Print Method for the Anchor-Based Approach for Individuals — print.cs_anchor_individual_within","text":"x object class cs_anchor_individual_within ... Additional arguments","code":""},{"path":"/reference/print.cs_anchor_individual_within.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Print Method for the Anchor-Based Approach for Individuals — print.cs_anchor_individual_within","text":"return value, called side effects","code":""},{"path":"/reference/print.cs_anchor_individual_within.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Print Method for the Anchor-Based Approach for Individuals — print.cs_anchor_individual_within","text":"","code":"cs_results <- claus_2020 |>   cs_distribution(id, time, hamd, pre = 1, post = 4, reliability = 0.8) cs_results #>  #> ── Clinical Significance Results ── #>  #> Distribution-based approach using the JT method. #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 29 |    0.72 #> Unchanged    | 10 |    0.25 #> Deteriorated |  1 |    0.03"},{"path":"/reference/print.cs_combined.html","id":null,"dir":"Reference","previous_headings":"","what":"Print Method for the Combined Approach — print.cs_combined","title":"Print Method for the Combined Approach — print.cs_combined","text":"Print Method Combined Approach","code":""},{"path":"/reference/print.cs_combined.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Print Method for the Combined Approach — print.cs_combined","text":"","code":"# S3 method for cs_combined print(x, ...)"},{"path":"/reference/print.cs_combined.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Print Method for the Combined Approach — print.cs_combined","text":"x object class cs_combined ... Additional arguments","code":""},{"path":"/reference/print.cs_combined.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Print Method for the Combined Approach — print.cs_combined","text":"return value, called side effects","code":""},{"path":"/reference/print.cs_combined.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Print Method for the Combined Approach — print.cs_combined","text":"","code":"cs_results <- claus_2020 |>   cs_combined(id, time, hamd, pre = 1, post = 4, reliability = 0.8) cs_results #>  #> ── Clinical Significance Results ── #>  #> Combined approach using the JT and statistical approach. #>  #> Category     |  n | Percent #> --------------------------- #> Recovered    | 26 |    0.65 #> Improved     |  3 |    0.07 #> Unchanged    | 10 |    0.25 #> Deteriorated |  1 |    0.03 #> Harmed       |  0 |    0.00"},{"path":"/reference/print.cs_distribution.html","id":null,"dir":"Reference","previous_headings":"","what":"Print Method for the Distribution-Based Approach — print.cs_distribution","title":"Print Method for the Distribution-Based Approach — print.cs_distribution","text":"Print Method Distribution-Based Approach","code":""},{"path":"/reference/print.cs_distribution.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Print Method for the Distribution-Based Approach — print.cs_distribution","text":"","code":"# S3 method for cs_distribution print(x, ...)"},{"path":"/reference/print.cs_distribution.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Print Method for the Distribution-Based Approach — print.cs_distribution","text":"x object class cs_distribution ... Additional arguments","code":""},{"path":"/reference/print.cs_distribution.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Print Method for the Distribution-Based Approach — print.cs_distribution","text":"return value, called side effects","code":""},{"path":"/reference/print.cs_distribution.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Print Method for the Distribution-Based Approach — print.cs_distribution","text":"","code":"cs_results <- claus_2020 |>   cs_distribution(id, time, hamd, pre = 1, post = 4, reliability = 0.8)  cs_results #>  #> ── Clinical Significance Results ── #>  #> Distribution-based approach using the JT method. #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 29 |    0.72 #> Unchanged    | 10 |    0.25 #> Deteriorated |  1 |    0.03"},{"path":"/reference/print.cs_percentage.html","id":null,"dir":"Reference","previous_headings":"","what":"Print Method for the Percentange-Change Approach — print.cs_percentage","title":"Print Method for the Percentange-Change Approach — print.cs_percentage","text":"Print Method Percentange-Change Approach","code":""},{"path":"/reference/print.cs_percentage.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Print Method for the Percentange-Change Approach — print.cs_percentage","text":"","code":"# S3 method for cs_percentage print(x, ...)"},{"path":"/reference/print.cs_percentage.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Print Method for the Percentange-Change Approach — print.cs_percentage","text":"x object class cs_percentage ... Additional arguments","code":""},{"path":"/reference/print.cs_percentage.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Print Method for the Percentange-Change Approach — print.cs_percentage","text":"return value, called side effects","code":""},{"path":"/reference/print.cs_percentage.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Print Method for the Percentange-Change Approach — print.cs_percentage","text":"","code":"cs_results <- claus_2020 |>   cs_distribution(id, time, hamd, pre = 1, post = 4, reliability = 0.8) cs_results #>  #> ── Clinical Significance Results ── #>  #> Distribution-based approach using the JT method. #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 29 |    0.72 #> Unchanged    | 10 |    0.25 #> Deteriorated |  1 |    0.03"},{"path":"/reference/print.cs_statistical.html","id":null,"dir":"Reference","previous_headings":"","what":"Print Method for the Statistical Approach — print.cs_statistical","title":"Print Method for the Statistical Approach — print.cs_statistical","text":"Print Method Statistical Approach","code":""},{"path":"/reference/print.cs_statistical.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Print Method for the Statistical Approach — print.cs_statistical","text":"","code":"# S3 method for cs_statistical print(x, ...)"},{"path":"/reference/print.cs_statistical.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Print Method for the Statistical Approach — print.cs_statistical","text":"x object class cs_distribution ... Additional arguments","code":""},{"path":"/reference/print.cs_statistical.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Print Method for the Statistical Approach — print.cs_statistical","text":"return value, called side effects","code":""},{"path":"/reference/print.cs_statistical.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Print Method for the Statistical Approach — print.cs_statistical","text":"","code":"cs_results <- claus_2020 |>   cs_statistical(id, time, hamd, pre = 1, post = 4, m_functional = 8, sd_functional = 7) cs_results #>  #> ── Clinical Significance Results ── #>  #> Statistical approach using the JT method. #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 26 |    0.65 #> Unchanged    | 13 |    0.33 #> Deteriorated |  1 |    0.03"},{"path":"/reference/summary.cs_anchor_group_between.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary Method for the Anchor-Based Approach for Groups (Between) — summary.cs_anchor_group_between","title":"Summary Method for the Anchor-Based Approach for Groups (Between) — summary.cs_anchor_group_between","text":"Summary Method Anchor-Based Approach Groups ()","code":""},{"path":"/reference/summary.cs_anchor_group_between.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary Method for the Anchor-Based Approach for Groups (Between) — summary.cs_anchor_group_between","text":"","code":"# S3 method for cs_anchor_group_between summary(object, ...)"},{"path":"/reference/summary.cs_anchor_group_between.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary Method for the Anchor-Based Approach for Groups (Between) — summary.cs_anchor_group_between","text":"object object class cs_anchor_group_between ... Additional arguments","code":""},{"path":"/reference/summary.cs_anchor_group_between.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary Method for the Anchor-Based Approach for Groups (Between) — summary.cs_anchor_group_between","text":"return value, called side effects ","code":""},{"path":"/reference/summary.cs_anchor_group_between.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Summary Method for the Anchor-Based Approach for Groups (Between) — summary.cs_anchor_group_between","text":"","code":"cs_results <- antidepressants |>   cs_anchor(     patient,     measurement,     post = \"After\",     mom_di,     mid_improvement = 8,     target = \"group\",     effect = \"between\",     group = condition   )  summary(cs_results) #>  #> ── Clinical Significance Results ── #>  #> Groupwise anchor-based analysis of clinical significance (between groups) with #> a 8 point decrease in instrument scores (mom_di) indicating a clinical #> significant improvement. #>  #>  #> ── Group Level Results  #>  #> Group 1   | Group 2          | Median Difference | [Lower | Upper] | CI-Level | n (1) | n (2) | Category                            #> ----------------------------------------------------------------------------------------------------------------------------------- #> Wait List | Inactive Placebo | -11.70            | -13.38 | -10.06 | 0.95     | 152   | 130   | Large clinically significant effect #> Wait List | Active Placebo   | -17.71            | -19.42 | -15.92 | 0.95     | 152   | 121   | Large clinically significant effect #> Wait List | Antidepressant   | -18.45            | -20.16 | -16.76 | 0.95     | 152   | 152   | Large clinically significant effect"},{"path":"/reference/summary.cs_anchor_group_within.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary Method for the Anchor-Based Approach for Groups (Within) — summary.cs_anchor_group_within","title":"Summary Method for the Anchor-Based Approach for Groups (Within) — summary.cs_anchor_group_within","text":"Summary Method Anchor-Based Approach Groups (Within)","code":""},{"path":"/reference/summary.cs_anchor_group_within.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary Method for the Anchor-Based Approach for Groups (Within) — summary.cs_anchor_group_within","text":"","code":"# S3 method for cs_anchor_group_within summary(object, ...)"},{"path":"/reference/summary.cs_anchor_group_within.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary Method for the Anchor-Based Approach for Groups (Within) — summary.cs_anchor_group_within","text":"object object class cs_anchor_group_within ... Additional arguments","code":""},{"path":"/reference/summary.cs_anchor_group_within.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary Method for the Anchor-Based Approach for Groups (Within) — summary.cs_anchor_group_within","text":"return value, called side effects ","code":""},{"path":"/reference/summary.cs_anchor_group_within.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Summary Method for the Anchor-Based Approach for Groups (Within) — summary.cs_anchor_group_within","text":"","code":"cs_results <- claus_2020 |>   cs_anchor(     id,     time,     bdi,     pre = 1,     post = 4,     mid_improvement = 8,     target = \"group\"   )  summary(cs_results) #>  #> ── Clinical Significance Results ── #>  #> Groupwise anchor-based analysis of clinical significance (within groups) with a #> 8 point decrease in instrument scores (bdi) indicating a clinical significant #> improvement. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #>  #> ── Group Level Results  #>  #> Difference | [Lower | Upper] | CI-Level | n  | Category                               #> ------------------------------------------------------------------------------------- #> -9.34      | -13.09 | -5.77  | 0.95     | 40 | Probably clinically significant effect"},{"path":"/reference/summary.cs_anchor_individual_within.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary Method for the Anchor-Based Approach — summary.cs_anchor_individual_within","title":"Summary Method for the Anchor-Based Approach — summary.cs_anchor_individual_within","text":"Summary Method Anchor-Based Approach","code":""},{"path":"/reference/summary.cs_anchor_individual_within.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary Method for the Anchor-Based Approach — summary.cs_anchor_individual_within","text":"","code":"# S3 method for cs_anchor_individual_within summary(object, ...)"},{"path":"/reference/summary.cs_anchor_individual_within.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary Method for the Anchor-Based Approach — summary.cs_anchor_individual_within","text":"object object class cs_anchor_individual_within ... Additional arguments","code":""},{"path":"/reference/summary.cs_anchor_individual_within.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary Method for the Anchor-Based Approach — summary.cs_anchor_individual_within","text":"return value, called side effects ","code":""},{"path":"/reference/summary.cs_combined.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary Method for the Combined Approach — summary.cs_combined","title":"Summary Method for the Combined Approach — summary.cs_combined","text":"Summary Method Combined Approach","code":""},{"path":"/reference/summary.cs_combined.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary Method for the Combined Approach — summary.cs_combined","text":"","code":"# S3 method for cs_combined summary(object, ...)"},{"path":"/reference/summary.cs_combined.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary Method for the Combined Approach — summary.cs_combined","text":"object object class cs_combined ... Additional arguments","code":""},{"path":"/reference/summary.cs_combined.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary Method for the Combined Approach — summary.cs_combined","text":"return value, called side effects ","code":""},{"path":"/reference/summary.cs_combined.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Summary Method for the Combined Approach — summary.cs_combined","text":"","code":"cs_results <- claus_2020 |>   cs_combined(id, time, hamd, pre = 1, post = 4, reliability = 0.8)  summary(cs_results) #>  #> ── Clinical Significance Results ── #>  #> Combined analysis of clinical significance using the JT and statistical #> approach method for calculating the RCI and population cutoffs. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> The outcome was hamd and the reliability was set to 0.8. #>  #> The cutoff type was a with a value of 18.17 based on the following sumamry #> statistics: #>  #>  #> ── Population Characteristics  #> M Clinical | SD Clinical | M Functional | SD Functional #> ------------------------------------------------------- #> 24.85      |        3.34 |          --- |           --- #>  #>  #> ── Individual Level Results  #> Category     |  n | Percent #> --------------------------- #> Recovered    | 26 |    0.65 #> Improved     |  3 |    0.07 #> Unchanged    | 10 |    0.25 #> Deteriorated |  1 |    0.03 #> Harmed       |  0 |    0.00"},{"path":"/reference/summary.cs_distribution.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary Method for the Distribution-Based Approach — summary.cs_distribution","title":"Summary Method for the Distribution-Based Approach — summary.cs_distribution","text":"Summary Method Distribution-Based Approach","code":""},{"path":"/reference/summary.cs_distribution.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary Method for the Distribution-Based Approach — summary.cs_distribution","text":"","code":"# S3 method for cs_distribution summary(object, ...)"},{"path":"/reference/summary.cs_distribution.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary Method for the Distribution-Based Approach — summary.cs_distribution","text":"object object class cs_distribution ... Additional arguments","code":""},{"path":"/reference/summary.cs_distribution.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary Method for the Distribution-Based Approach — summary.cs_distribution","text":"return value, called side effects ","code":""},{"path":"/reference/summary.cs_distribution.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Summary Method for the Distribution-Based Approach — summary.cs_distribution","text":"","code":"cs_results <- claus_2020 |>   cs_distribution(id, time, hamd, pre = 1, post = 4, reliability = 0.8)  summary(cs_results) #>  #> ── Clinical Significance Results ── #>  #> Distribution-based analysis of clinical significance using the JT method for #> calculating the RCI. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> The outcome was hamd and the reliability was set to 0.8. #>  #>  #> ── Individual Level Results  #> Category     |  n | Percent #> --------------------------- #> Improved     | 29 |    0.72 #> Unchanged    | 10 |    0.25 #> Deteriorated |  1 |    0.03"},{"path":"/reference/summary.cs_percentage.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary Method for the Percentage-Change Approach — summary.cs_percentage","title":"Summary Method for the Percentage-Change Approach — summary.cs_percentage","text":"Summary Method Percentage-Change Approach","code":""},{"path":"/reference/summary.cs_percentage.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary Method for the Percentage-Change Approach — summary.cs_percentage","text":"","code":"# S3 method for cs_percentage summary(object, ...)"},{"path":"/reference/summary.cs_percentage.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary Method for the Percentage-Change Approach — summary.cs_percentage","text":"object object class cs_percentage ... Additional arguments","code":""},{"path":"/reference/summary.cs_percentage.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary Method for the Percentage-Change Approach — summary.cs_percentage","text":"return value, called side effects ","code":""},{"path":"/reference/summary.cs_percentage.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Summary Method for the Percentage-Change Approach — summary.cs_percentage","text":"","code":"cs_results <- claus_2020 |>   cs_percentage(id, time, hamd, pre = 1, post = 4, pct_improvement = 0.5)  summary(cs_results) #>  #> ── Clinical Significance Results ── #>  #> Percentage-change analysis of clinical significance with a 50% decrease in #> instrument scores indicating a clinical significant improvement. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #>  #> ── Individual Level Results  #>  #> Category     |  n | Percent #> --------------------------- #> Improved     | 16 |    0.40 #> Unchanged    | 24 |    0.60 #> Deteriorated |  0 |    0.00"},{"path":"/reference/summary.cs_statistical.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary Method for the Statistical Approach — summary.cs_statistical","title":"Summary Method for the Statistical Approach — summary.cs_statistical","text":"Summary Method Statistical Approach","code":""},{"path":"/reference/summary.cs_statistical.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary Method for the Statistical Approach — summary.cs_statistical","text":"","code":"# S3 method for cs_statistical summary(object, ...)"},{"path":"/reference/summary.cs_statistical.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary Method for the Statistical Approach — summary.cs_statistical","text":"object object class cs_distribution ... Additional arguments","code":""},{"path":"/reference/summary.cs_statistical.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary Method for the Statistical Approach — summary.cs_statistical","text":"return value, called side effects ","code":""},{"path":"/reference/summary.cs_statistical.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Summary Method for the Statistical Approach — summary.cs_statistical","text":"","code":"cs_results <- claus_2020 |>   cs_statistical(     id,     time,     hamd,     pre = 1,     post = 4,     m_functional = 8,     sd_functional = 7   )  summary(cs_results) #>  #> ── Clinical Significance Results ── #>  #> Statistical approach of clinical significance using the JT method for #> calculating the population cutoff. #>  #> There were 43 participants in the whole dataset of which 40 (93%) could be #> included in the analysis. #>  #> The cutoff type was a with a value of 18.17 based on the following sumamry #> statistics: #>  #>  #> ── Population Characteristics  #> M Clinical | SD Clinical | M Functional | SD Functional #> ------------------------------------------------------- #> 24.85      |        3.34 |            8 |             7 #>  #>  #> ── Individual Level Results  #> Category     |  n | Percent #> --------------------------- #> Improved     | 26 |    0.65 #> Unchanged    | 13 |    0.33 #> Deteriorated |  1 |    0.03"},{"path":"/reference/summary_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Get A Summary Table From A cs_analysis Object — cs_get_summary","title":"Get A Summary Table From A cs_analysis Object — cs_get_summary","text":"Retrieve summary table tidy tibble format. especially useful plot results conduct sensitivity analyses.","code":""},{"path":"/reference/summary_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get A Summary Table From A cs_analysis Object — cs_get_summary","text":"","code":"cs_get_summary(x, ...)  # S3 method for default cs_get_summary(x, which = c(\"individual\", \"group\"), ...)  # S3 method for cs_anchor_group_within cs_get_summary(x, ...)  # S3 method for cs_anchor_group_between cs_get_summary(x, ...)"},{"path":"/reference/summary_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get A Summary Table From A cs_analysis Object — cs_get_summary","text":"x object class cs_analysis ... Additional arguments passed respective method level summary table return. necessary method \"HA\" since two summary tables reported. Available individual, default group, group level results according Hageman & Arrindell (1999)","code":""},{"path":"/reference/summary_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get A Summary Table From A cs_analysis Object — cs_get_summary","text":"tibble clinical significance categories","code":""},{"path":"/reference/summary_table.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Get A Summary Table From A cs_analysis Object — cs_get_summary","text":"Hageman, W. J., & Arrindell, W. . (1999). Establishing clinically significant change: increment precision distinction individual group level analysis. Behaviour Research Therapy, 37(12), 1169–1193. https://doi.org/10.1016/S0005-7967(99)00032-7","code":""},{"path":[]},{"path":"/reference/summary_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get A Summary Table From A cs_analysis Object — cs_get_summary","text":"","code":"anchor_results <- claus_2020 |>   cs_anchor(     id,     time,     bdi,     pre = 1,     post = 4,     mid_improvement = 8   )  cs_get_summary(anchor_results) #> # A tibble: 3 × 3 #>   category         n percent #>   <fct>        <int>   <dbl> #> 1 Improved        20   0.5   #> 2 Unchanged       17   0.425 #> 3 Deteriorated     3   0.075   # Get summary table for a group level analysis anchor_results_grouped <- claus_2020 |>   cs_anchor(     id,     time,     bdi,     pre = 1,     post = 4,     mid_improvement = 8,     target = \"group\"   )  cs_get_summary(anchor_results_grouped) #> # A tibble: 1 × 6 #>   difference lower upper    ci     n category                               #>        <dbl> <dbl> <dbl> <dbl> <int> <chr>                                  #> 1      -9.46 -13.0 -5.93  0.95    40 Probably clinically significant effect   # Get group-wise summary table for the Hageman & Arrindell method combined_results <- claus_2020 |>   cs_combined(     id,     time,     bdi,     pre = 1,     post = 4,     m_functional = 8,     sd_functional = 8,     reliability = 0.80,     rci_method = \"HA\"   )  cs_get_summary(combined_results) #> # A tibble: 5 × 3 #>   category         n percent #>   <fct>        <int>   <dbl> #> 1 Recovered        7   0.175 #> 2 Improved        18   0.45  #> 3 Unchanged       15   0.375 #> 4 Deteriorated     0   0     #> 5 Harmed           0   0     cs_get_summary(combined_results, which = \"group\") #> # A tibble: 2 × 2 #>   category   percent #>   <chr>        <dbl> #> 1 Changed      0.841 #> 2 Functional   0.354"},{"path":[]},{"path":"/news/index.html","id":"breaking-changes-development-version","dir":"Changelog","previous_headings":"","what":"Breaking changes","title":"clinicalsignificance (development version)","text":"cs_anchor() (Anchor-based approaches) cs_percentage()(Percentage-change approaches) cs_distribution()(Distribution-based approaches) cs_statistical()(Statistical approaches) cs_combined()(Combined approaches) function clinical_significance() used combined approach (distribution-based statistical). identical analysis can carried cs_combined(). function check_cutoff() deprecated. method = \"HLM, participants three data points used. , participants least three data points (.e., 4 ) used. package now offers combined approaches: classic combination statistical distribution-based approaches also combination statistical anchor-based approaches","code":""},{"path":"/news/index.html","id":"new-features-development-version","dir":"Changelog","previous_headings":"","what":"New features","title":"clinicalsignificance (development version)","text":"can now specify significance level want analysis based significance_level argument. default significance_level = 0.05. Note Phi max level set method = \"HA\" outlined article.","code":""},{"path":"/news/index.html","id":"minor-improvements-and-fixes-development-version","dir":"Changelog","previous_headings":"","what":"Minor improvements and fixes","title":"clinicalsignificance (development version)","text":"Change whole package use R’s native pipe operator |> Remove unnecessary dependency magrittr","code":""},{"path":[]},{"path":"/news/index.html","id":"breaking-changes-1-2-1","dir":"Changelog","previous_headings":"","what":"Breaking changes","title":"clinicalsignificance 1.2.1","text":"Remove default theming check_cutoff() plot functions","code":""},{"path":"/news/index.html","id":"minor-improvements-and-fixes-1-2-1","dir":"Changelog","previous_headings":"","what":"Minor improvements and fixes","title":"clinicalsignificance 1.2.1","text":"Improve documentation datasets Include examples summary() plot() method","code":""},{"path":"/news/index.html","id":"clinicalsignificance-120","dir":"Changelog","previous_headings":"","what":"clinicalsignificance 1.2.0","title":"clinicalsignificance 1.2.0","text":"CRAN release: 2022-12-08","code":""},{"path":"/news/index.html","id":"breaking-changes-1-2-0","dir":"Changelog","previous_headings":"","what":"Breaking changes","title":"clinicalsignificance 1.2.0","text":"Remove default theming plot() give user control overall appearance","code":""},{"path":"/news/index.html","id":"minor-improvements-and-fixes-1-2-0","dir":"Changelog","previous_headings":"","what":"Minor improvements and fixes","title":"clinicalsignificance 1.2.0","text":"implementation tidyeval principles since aes_() deprecated Small improvements vignettes Better documentation functions","code":""},{"path":"/news/index.html","id":"clinicalsignificance-110","dir":"Changelog","previous_headings":"","what":"clinicalsignificance 1.1.0","title":"clinicalsignificance 1.1.0","text":"Fix HLM method empirical bayes estimation (#2). now relies lme4 package Consider instrument direction group level summaries HA method (#1) done initial release","code":""},{"path":"/news/index.html","id":"clinicalsignificance-101","dir":"Changelog","previous_headings":"","what":"clinicalsignificance 1.0.1","title":"clinicalsignificance 1.0.1","text":"Added NEWS.md file track changes package. Added package URLs DESCRIPTION, including one bug reports New package logo","code":""}]
